Emily procter plastic surgery before and aftermily procter

What is wrong with my coworker) friend/foe or frenemy? Coworker F60 and I F49 have had a friendship that began by her inviting me to a Christmas play.

2024.05.10 07:50 Comfortable_Wrap1288 What is wrong with my coworker) friend/foe or frenemy? Coworker F60 and I F49 have had a friendship that began by her inviting me to a Christmas play.

Tl;dr- my coworker manipulates me. I'm a giver she takes. How do I unfurl myself from the interactions.?
She (I'll call her "Emily") is in a lower position at work than I, she in a service capacity and I am in a professional office capacity. Emily is AfroAmerican and I am white/asian. I took a liking to Emily from the beginning because she was approachable, bubbly, friendly, and kind. We shared interested in clothing and makeup. Also - humor. With time, I noticed that she seemed to request a lot of things from me either through subtle suggestions to be manipulative. Or, direct requests. Usually the former. I am a giver by nature. With time, I came to realize not only was she a taker but also and this is important, things I was sharing with her do not go undshared. I basically had to glean this from the fact that she tells me things about several of the other people in the office. I was slow to catch on. I realized had likely sharedsomething I had complained about about another service employee. I felt safe in sharing my complaint with her because she had disparaged this fellow employee and also complained about his work. Then like the day after I had shared with her my complaints, I saw her buddying up with him chewing the fat. At this time, I had to take a Stern stock and accounting of my position and realized it could be very dangerous her talking about me to staff. Apparently, she speaks with our second in charge and has told me a great great deal about her personal life and health matters. That's just one example.
So, it is at that time I basically decided to cut her off. A big part of it had to do with the fact that I would share a lot about my you know daily concerns with her on text messaging. She responded to almost none of them. I realize, she has less education than me.. but, she seems to be able to conceptualize and communicate when it's something of importance to her. Ergo, I realized it was pretty much a one-way street. I blocked herself she did something weird and passive aggressive and approached me to see if I would be interested in something and I had to unblock her to make it not an awkward communication moment. And of course, as a result - she realized I had blocked her before that moment. I pretty much haven't really communicated with her except for hello at the office and you know the occasional kind of shared conversation about things that are currently happening at the office that everyone needs to communicate about. But, today - - was different. Perhaps it was my mistake, I cracked open the door again by sending her a text message yesterday because I know she has hip surgery coming up soon and she was gone from work yesterday and I wasn't sure when the surgery was scheduled and I felt badly to not even be in communication at all at a time when she's going to be having major surgery. I guess I kind of feel like, her home life sucks with her husband and son. Her housing life sucks and I've been to her home it's not great. We're just in completely different worlds we come from different class so to speak structures. And I can't see that she's transcended her circumstances from what she came and it's understandable. So she wrote me back and said the surgery wasn't yesterday and said I was a good friend I had offered to help her you know complete her FMLA paperwork if she needed help because she had asked me about it previously and she was really bad at figuring out the details. So, fast forward today she ambushes me, tells me tomorrow is my birthday. I won't have my birthday celebrated by my husband or my son. Her mother I know has passed many years since. She goes on to say how we celebrate office birthdays and no one's ever done that for her and she wishes someone would do it. Then, she goes on to say that she doesn't want a cheesecake or this kind of cake or that kind of cake not a Frozen cake she specifically tells me what kind of goddamn cake she wants. And i, like a moron, fall for it hook line and sinker. I guess, I thought huh well there is truth in what she's saying we don't in include her in celebrations the way we do for a lot of the other staff because she doesn't actually work for our company she works for a service company. Wanting to avoid an awkward situation and wishing to have a peaceful work environment I guess I said I would make sure she got a cake. Thinking to myself, it only cost me a couple bucks for a mix cake and a couple bucks for some frosting. Bada being bad a bang how bad could it be. Then, I think crap what she talking about the way we celebrate the other coworkers? Oh, I realize she means we put streamers and signs balloons whatever on there cubicle. So, I spring into action I get some stuff delivered from the store balloons bowls she had told me she wanted cake and ice cream and she would cry if she didn't get those things. It was just the weirdest effing thing ever. And I just you melted at the idea like oh my God here's someone who doesn't have all these things and she's telling me and I'm feeling bad for her. And, I love doing those things for people. And she knows this. Previously, she tried to get me to have a party this month or next month she she was saying oh gosh we haven't had a party in a while and we should really do something. And I was quick to respond at that time I said great Emily why don't you plan that let me know. This time, I was unprepared and maybe I was vulnerable because I let her in to a little crack in my psyche because I felt a sense of sympathy maybe for her pending medical procedure. All of this is to say, I'm trying to figure out one, how to proceed in the future. Too, what is the psychological dynamic that is going on between she and i. I wish to understand what is it about her and what is it about I that makes this go forward. I'm thinking, mostly, it's because I have a manipulative narcissistic mother. I naturally respond to her manipulations easily because I care for my mother and.. she's my mother! I had realized my sensitivity to the b******* and manipulation and that's kind of why I cut things off with Emily.
So now, I had bought a cake because I was really tired and didn't want to make a cake and I thought hey okay this will be less stressful. Another co-worker, I'll call her ingrid volunteered to help me pay for the cake as she is a sucker like I am to people who need things.
So, how do I get out of this cycle moving forward, should I basically just not talk to this woman anymore except for very Kurt office interactions? Is she worthy of my sympathy? At any level?
She is psycho or she have feelings I mean? There have been times when I have told her a ton about myself and then she completely switches the subject like she didn't hear a single thing I said. Ostensibly, this is narcissistic behavior. She acts passive aggressive towards me. She tries to get me to do things for her I feel like she cracks open the door that's how we became friends in the first place she said she needed help with something and no one else would help her with it and she put in the sympathy statement and voila I ended up at her house helping her install a printer.
I don't know, I feel like such a sucker, and I don't want this behavior to continue but it's really really hard for me to just not interact with someone who has this kind of dynamic. She's she's borderline safe and friendly but then she's borderline scary ass dangerous manipulative gossiping passive aggressive. I'm almost afraid not to do s*** for her like what will she do? I mean she left something on my desk I didn't know who left it but I kind of deduced it was probably her. It was a wall sign you know the chief kind you might get at the dollar store? It's like plastic or ceramic I don't know what but I guess she had to hang on her wall and it shattered. She left on my desk taped together badly with some super glue. Later, she mentions that she had done so and told me I would be doing this for her she didn't really ask she said she knew how much I would like doing that since I loved craft projects.
I do not like fixing s*** for people it's a chore. I do it for the people in my life who I care about that do things for me. I had let it sit on my desk for several days because I was just irritated like, who the f*** do you think I am and why what I want to fix your crap for you? She was rude and passive aggressive with me at the office like wouldn't really greet me. So, that resulted in me taking it and putting in my car so that she would see there was some potential that I might be fixing it. I, have zero interest in fixing it. Also, it's really cheap. Why would anyone want to keep that?
The bigger issue is, of course, her repeated attempts to manipulate me in my sadly susceptibility to these attempts. It's so confusing. On the one hand she seems like such an innocuous person on the other hand she can make me spend a s*** ton of money in a short period of time just by suggesting some things to me. I bought a cake balloons decorations have them delivered all because I thought, "well this is terrible, she can't not have her birthday celebrated she needs to feel fit in and the class ism bothers me we have to try and make everyone feel equal."
Yes it's total bullshit. Yikes help me see reason. Just in writing this, I'm seeing how clear the pattern is: she'll compliment me she'll suck me into conversation, she'll ask for something or subtly suggest something that she needs or wants. Then she demands specifically a greater request than even began originally. I've even wondered if she's just gearing up to scam me in a much bigger way. This could be terrible.
I'm kind of feeling like just irritated about the whole thing to wear, I don't think I want to take the cake in tomorrow. I had bought ice cream bowls spoons you know party supplies. And I just realized, sitting here explaining it to you all: it makes no sense. I'm rewarding her for manipulating me. If I ever expect it to stop, I have to not follow through. With what I have promised or what she has asked me to do.
submitted by Comfortable_Wrap1288 to relationship_advice [link] [comments]


2024.04.03 18:01 MedicineChess Almost done using this bottle of hand soap for my dishes.

Almost done using this bottle of hand soap for my dishes.
Maybe I’m the idiot, but I didn’t even realize Dawn made hand soap and put it in the same fricken bottle as the dish soap.
For reference, I checked the back up bottle under the sink of Dawn Platinum my roommate bought and that does in fact say it’s for dishes.
submitted by MedicineChess to mildlyinfuriating [link] [comments]


2024.03.23 10:27 Salty_Rise What has this flash spray done to my cooker hob?

What has this flash spray done to my cooker hob?
It looks like it’s taken a ‘layer’ of something off. The back of the bottle says it’s safe to use on stainless steel.
Either this cooker hob isn’t stainless steel or something weird has happened.
Anyone seen this before?
submitted by Salty_Rise to CleaningTips [link] [comments]


2024.03.22 07:08 lovelifelivelife [Discussion] Sea of Tranquility by Emily St. John Mandel Part 5 to End

Hello anomaly investigators,
Welcome to the third and final check in of the Sea of Tranquility by Emily St. John Mandel. It was a wild ride and these final chapters are where everything comes together. I've included a summary if you require it below.
Part 5
We’re back on the book tour where Gaspery is interviewing Olive. Olive recounts her experience of the incident- she felt like she was in two places at once. And then Gaspery warns her to leave Earth where she was supposed to die. She does so and every thought plays back in her head that she escaped death. The colony goes into lockdown and everyone is communicating with holograms. Then one day, she overhears a conversation happening in her backyard between Gaspery and Zoey. They were arguing and Gaspery say that he isn’t going to run away from the consequences. Later, Olive sees his name in an inmate list, sentenced to 20 years in a double homicide. She is still trying to grasp the fact that she narrowly escaped death.
Part 6
Zoey and Gaspery reunite in November 30, 2203, in Colony Two. Zoey knows about the breach and advises him, after Gaspery asks, to try solving the anomaly. She helps him get to the location and time of where Vincent Smith filmed it. He experiences it for himself and then travels back to where he left.
Zoey informs him that he is taken out of commission. He begs her to help him so he can get another layer of confirmation and she does, helping him get to 2 more destinations to meet Vincent and Edwin.
He gets the confirmation from Vincent. Then thinks of Mirella and what she told him about his fate in the future.
Part 7
He meets Edwin in 1918 and he is a depressed war hero without a foot. He gets the confirmation on recording from Edwin, then reveals who he is in hopes that Edwin won’t end up dying in an Asylum.
Gaspery decides to return to the Time Institute despite knowing that he could have taken off his tracker and stayed in 1918. He finds out that Edwin dies of the flu anyway. Ephrem knocks him out with a drug and then travels to the twentieth century where he is framed for a double homicide and where he meets Mirella. He ends up in prison where he scratches “No star burns forever” on the walls and ponders about his actions till date.
Part 8
Gaspery is 60 and transferred to the prison hospital due to heart issues. He reminisces about the past before Zoey appears and transports him to 2172 in Oaklahoma city where she sets him up at a farm and tells him she is employed by another organisation with a time machine.
Fearing that he would be identified by the Time Institute, he undergoes plastic surgery. When he wakes up, he finds that he recognises his new face. He learns how to play the violin from Talia. Talia tells him that she managed to escape to the far colonies with Zoey. He gets married to Talia. Talia passes away because of an aneurysm. Gaspery moves to the city with his dog, Odie.
In October 2195, Gaspery plays his violin in the airship terminal where Olive walks past and his past self appears, his first interview at the Time Institute. And that's when he senses that the stimulation is coming apart, as it detects 3 Gasperys - one in the forest, one playing the violin and one about to interview him. He can see the corrupted moment where a wave of darkness appears behind the younger Gaspery approaching him. And then everything was as it is supposed to be. And he realises then that it was him who caused the anomaly.
As he talks to Gaspery, following the script of what he remembers, he thinks about his current life. How he felt when Talia passed on, and his current daily life of walking and seeing everyone go somewhere while feeling that he had already moved too fast and gone too far.
I hope you all had a good time reading this one! Questions are in the comments as usual, see you there!
submitted by lovelifelivelife to bookclub [link] [comments]


2024.02.27 08:59 aishwarya00 Feminine Hygiene Product Market Industry Leaders Respond to Changing Consumer Preferences

Feminine Hygiene Product Market Industry Leaders Respond to Changing Consumer Preferences
Industry Leaders Respond to Changing Consumer Preferences Industry leaders in the feminine hygiene product market are proactively responding to changing consumer preferences. Recognizing the demand for transparency, sustainable practices, and product diversity, these leaders are driving innovation within their organizations. By investing in research and development, staying ahead of trends, and prioritizing customer feedback, industry leaders are not only shaping the current market but also influencing the future trajectory of feminine hygiene products. The global feminine hygiene product market is experiencing significant growth, fueled by increasing awareness about women's health and hygiene, changing consumer attitudes, and innovations in product design. As conversations around menstrual health become more open, The global revenue from the feminine hygiene product market stands at US$ 29.5 Bn in 2022, with the global market expected to grow at a CAGR of 6.0% to reach a valuation of approximately US$ 56.5 Bn by the end of 2033. Market Drivers: Rising Awareness and Education: Growing awareness about women's health and hygiene, coupled with educational initiatives, is a key driver for the feminine hygiene product market. Public campaigns, educational programs, and social media discussions contribute to changing perceptions and fostering informed choices. Product Innovation and Diversification: Continuous innovation in product design and materials, including the introduction of organic and sustainable options, drives market growth. Manufacturers are developing products that cater to specific needs, offering a diverse range of options such as tampons, sanitary pads, menstrual cups, and period panties. Shift Towards Sustainable Practices: Increasing environmental consciousness among consumers is leading to a demand for eco-friendly and sustainable feminine hygiene products. Manufacturers are responding by incorporating biodegradable materials, reducing packaging waste, and emphasizing product sustainability. Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2032 – By Product Type, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa): https://www.persistencemarketresearch.com/market-research/feminine-hygiene-product-market.asp Market Restraints: Stigma and Cultural Barriers: Despite progress in breaking the taboo around menstrual health, stigma and cultural barriers persist in certain regions. Societal attitudes can impact the adoption of certain feminine hygiene products and hinder open conversations about menstruation. Economic Constraints: Affordability remains a concern for some consumers, particularly in low-income regions. The cost of feminine hygiene products may limit accessibility, leading to the use of alternative, potentially less hygienic methods, impacting overall market growth. Supply Chain Disruptions: The feminine hygiene product market is susceptible to supply chain disruptions, including raw material shortages, manufacturing challenges, and distribution issues. Events such as the COVID-19 pandemic highlighted vulnerabilities in the supply chain and logistics. Market Opportunities: E-commerce Expansion: The rise of e-commerce presents opportunities for increased accessibility to feminine hygiene products, especially in regions with limited physical retail presence. Online platforms provide a convenient and discreet way for consumers to purchase a wide variety of products. Global Health Initiatives: Collaborations with health organizations and NGOs to promote menstrual health education and hygiene initiatives can create opportunities for market players. Supporting global health campaigns and community outreach can contribute to brand loyalty and market expansion. Inclusivity and Product Customization: The market can benefit from a focus on inclusivity by catering to diverse needs, including products for different menstrual flow intensities, age groups, and specific health conditions. Customization options can enhance consumer satisfaction and brand loyalty. Market Segmentations: Product: Sanitary Napkins/Pads Tampons Panty liners Menstrual Cup Feminine Hygiene Wash Distribution Channel: Supermarket Convenience Stores Department Stores Retail Pharmacies Online Purchase Region: North America Latin America Europe South Asia East Asia Oceania Middle East & Africa Regional Market Dynamics: North America: The North American feminine hygiene product market is characterized by a high level of awareness, product innovation, and the availability of a wide range of options. Increasing demand for organic and sustainable products contributes to market growth in the region. Europe: Europe has a mature feminine hygiene product market, driven by a strong emphasis on sustainability and environmental responsibility. Manufacturers in the region are increasingly focused on offering eco-friendly and organic options to meet consumer preferences. Asia-Pacific: The Asia-Pacific region is a significant contributor to market growth, driven by population size, increasing awareness, and changing cultural attitudes. The market benefits from the expansion of e-commerce platforms, providing accessibility to a diverse range of products. Key Players: The feminine hygiene product market includes a mix of multinational corporations and emerging players. Some prominent players include: Kimberley Clark Corporation Procter and Gamble Unicharm Corporation Svenska Cellulosa Aktiebolaget SCA Johnson & Johnson Sanofi Ontex Edgewell Personal Care Lil-lets UK Limited Diva International Inc. Market Trends & Latest Developments: Sustainable Packaging: Manufacturers are increasingly focusing on sustainable packaging solutions, such as biodegradable materials and reduced plastic usage. Sustainable packaging aligns with environmental initiatives and resonates with eco-conscious consumers. Period Poverty Initiatives: Some companies are addressing period poverty by offering donation programs, providing free or subsidized products, and supporting menstrual health education initiatives. These efforts contribute to social responsibility and brand perception. Technology Integration: Innovations include the integration of technology into feminine hygiene products, such as smart menstrual cups and period tracking apps. These technologies aim to provide additional functionalities and enhance the overall user experience. Future Trends and Outlook: Advancements in Materials: Continued research and development in material science will likely lead to advancements in absorbent materials, enhancing product performance and comfort. Innovations may focus on biodegradable and eco-friendly materials. Telehealth and Education Platforms: The integration of telehealth services and educational platforms can offer convenient and accessible channels for women to seek advice, information, and consultation related to menstrual health and hygiene. Global Advocacy and Policy Initiatives: Collaborative efforts with governments and international organizations to advocate for policies supporting menstrual health, hygiene, and affordability can shape the future of the feminine hygiene product market on a global scale. The feminine hygiene product market is evolving with a focus on innovation, sustainability, and addressing social challenges. As market players navigate cultural nuances, address affordability concerns, and embrace emerging trends, the market is poised for continued growth and positive contributions to women's health globally. About Persistence Market Research: Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges. Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part. Contact Persistence Market Research Teerth Technospace, Unit B-704 Survey Number - 103, Baner Mumbai Bangalore Highway Pune 411045 India Email: sales@persistencemarketresearch.com Web: https://www.persistencemarketresearch.com
https://preview.redd.it/lqhd1yh543lc1.jpg?width=1920&format=pjpg&auto=webp&s=b391d012b01e814d7e3a9820fab2032267eab2d8
submitted by aishwarya00 to u/aishwarya00 [link] [comments]


2024.01.25 10:57 maximusaemilius Empyrean Iris: 2-146 Freak of nature (by Charlie Star)

FYI, this is a story COLLECTION. Lots of standalones technically. So, you can basically start to read at any chapter, no pre-read of the other chapters needed technically (other than maybe getting better descriptions of characters than: Adam Vir=human, Krill=antlike alien, Sunny=tall alien, Conn=telepathic alien). The numbers are (mostly) only for organization of posts and continuity.
OC Written by Charlie Stastarrfallknightrise,
Typed up and then posted here by me.
Proofreading and language check for some chapters by u/Finbar9800 u/BakeGullible9975 and u/Didnotseemecomein
Future Lore and fact check done by me.
Kinky! Uhhh I mean… freaky!
And the secret black market organ dealer Santa Claus strikes again!
Previous First Next
Want to find a specific one, see the whole list or check fanart?
Here is the link to the master-post.
Breaking News
The Galaxy is left stunned after the events of late yesterday evening, when a single armed shooter appeared from the crowd and fired on UNSC leader and cultural icon Admiral Vir during a routine press conference given at UNSC headquarters Fort Harmony on the eastern Mericandian coast. Reports describe the event as happening midway through Admiral Vir's address as the single, hooded female pushed through the crowd and drew a handgun on the Admiral, firing once before fleeing into the crowd. She was apprehended by armed security agents only moments later as she tried to flee the scene. On scene witnesses report that an accompanying marine tackled Admiral Vir to the ground just as the shot was fired.
In a statement made early this morning by Admiral Vir he reports that, "Thanks to the brave actions of Corporal Angel Ramirez I am alive and unharmed." Corporal Angel Ramirez is a decorated veteran of the UNSC deep space division and served his first tour aboard the UNSC Enterprise on its maiden voyage. Since then, he has served under Admiral Vir on both the UNSC Harbinger and most recently the Omen, distinguishing himself in combat during the Burg war and the Kree engagement. Our sources report that Corporal Ramirez was once an up-and-coming champion in the Mericandian winter Olympic ice skating team before joining the marines.
Reports say that the corporal came out of surgery early this morning and is in stable but critical condition.
The only question remains is who would attempt an assasination on such a beloved cultural icon. More on that with our crime reporter Jim Shaw.
Thank you, Emily, early this morning we received reports from Fort harmony officials that the name and identity of the shooter is 37 year old Adrea Halen, member of a traditionalist leaning moderate group called “the Hunt Party”, who have condemned Admiral Vir in the past for his support of legalizing extrial relationships. President Hunt, leader of the hunt Party and CEO of Hunt Metals said in a statement today. "Our party had nothing to do with Ms. Halen's actions, while we disagree with Admiral Vir on some fundamentals of government, we would definitely never attempt to silence him through violence. At the end of the day Admiral Vir has done far more good than he has bad and no man deserves to die due to his political views. What Ms Halen has done is condemnable, and the party does not support her actions."
Further comment was withheld until a later date. As of yet police have been unable to determine if she acted alone or with the assistance of the group. Police chief Henry Winzer added in his statement today, "Ms. Halen has not, as of yet, divulged her motives behind the shooting, however based on preliminary evidence of the scene it seems as if these were the actions of a woman acting alone. Detectives have been unable to find any correspondence between her and a third party and even her husband had been out of the country for the past few months and was visiting one of the colonies, doing research on ancient Greek democracy."
Her motive remains, as of yet, unknown. There is evidence of a radicalized political view, since she did attempt and target Admiral Vir, and some of her personal social media content has been leaked to the public, reporting her dissatisfaction with joining the GA and her open disgust for extrial activities, especially in regards her oldest son, who was owning a bar in Missouri, Mericanda, until he was travelling off earth, and started a relationship with a Finnari, before moving to Noctropolis. We have since been unable to contact him. The only description we were able to get was his bright green hair with a certain hairstyle.
In the past Admiral Vir has been known as a great political proponent in favor of extrial relationships, and a non-isolationist views having once said that, "Cooperation and companionship with the GA will be the bedrock of human expansion into space." With the popularity of Admiral Vir as a cultural Icon, it can be said that his political views have been influential on the younger upcoming generations of today, while the older populace still remains wary of political involvement with extraterrestrial life. In oth-
Adam shut off the TV, sinking back into one of the stiff plastic chairs that adorned the hospital waiting room. His eyes felt grainy and dry, and his head ached dully behind his eyes. Off in the corner of the room, much of Ramirez's family lay asleep on the plastic chairs, including his father and others who had arrived late last night. They had fallen asleep after a nurse ventured in a few hours to go to let them know that he was stable and alive. Adam himself had not been able to sleep, thinking about his friend, replaying the moment over and over in his head wondering if there was something he could have done to prevent all of this from happening. But the more he thought the more he realized that it was probably unlikely. He might have been able to dive out of the way himself before the shot was fired, but Ramirez was already in motion before that.
He couldn't have seen it coming, no one could have, and no one did.
Ramirez had just been the fastest.
He sunk back into his chair miserably and stared at the wall. There were no windows in this room, the guard detail had insisted upon it in case someone else tried for his life.
It all seemed so strange to him.
Why would anyone want to kill him?
He knew the answer though, as much as he wanted to think he was just some nobody, he wasn't anymore. He was... a political figure, someone who could influence what happened in the galaxy and there were plenty of people who weren't bound to agree with him on a lot of things.
He just wondered why he hadn't seen this coming sooner.
His implant buzzed, and he looked down to see that his mother was calling.
Whoopsie!
She wasn't going to be happy that she was just hearing about this over the news, but he knew he needed to talk to her. He stood and made his way into the hallway, where a protection detail eyed him hawkishly.
Closing the door behind him, so as not to disturb its sleeping occupants, he answered the call, speaking out loud as the implants in his throat and ear picked up the sound,
"Hey, mom."
"Adam! Adam are you alright! I just saw the news."
"Yeah, yea I'm ok."
He took a deep breath,
"Sorry I didn't call. It's just been kinda hectic."
"And you're sure you're ok?"
"Yeah, I mean, I feel like shit, but I’m not the one with bullet wounds..."
He trailed off. There was silence for a moment,
”I'm so sorry sweetheart, how is Angel?"
"Doctors haven't given us all the details yet, but he's at least alive and survived surgery."
"Thank goodness... We owe that boy."
"I know, mom... I know."
Just then he heard voices off down the hall and turned to see Dr. Krill and Dr Katie approaching from the wings.
"Mom, I've gotta go, but I'll call you as soon as I can, Ok?"
"Ok."
She let him go and he hung up as the two doctors approached.
"How is he!?"
They motioned him into the room and he followed just as Ramirez's family members were waking up.
Adam hovered near the door not entirely sure if he was supposed to be there. Ramirez's mother sat up,
"Is he ok!?"
Dr. Katie and Dr Krill glanced at Adam. Adam realized with Dr. patient confidentiality, and it being family, he probably wasn't supposed to be here. He went to step outside, but Ramirez's abuela waved him back.
Ramirez Abuela and Dr Katie nodded.
The little alien stepped forward towards the family,
"I have both good and bad news."
The group waited with bated breath.
"The good news is that your son made it through surgery. He is stable and recovering in the ICU."
He glanced over at Katie,
"The bullet went in through his back, through his right kidney and perforated some of his liver. We were able to fix the tears but the kidney... Was not salvageable."
The family glanced back and forth between each other,
"That... That's not so bad though. He has two..."
Krill shifted slightly,
"Weeeell about that… that is the remarkable thing and also the bad news but... Your son only had one kidney. We wouldn't have noticed it were it not for our focused imaging, but it seems he has lived with this defect his entire life without complication."
Dr. Katie Cut in just then,
"Since he was born with the defect, his body compensated. The kidney that was destroyed was much larger than average..."
She trailed off.
The family members looked between each other,
"So... So, what does this mean?”
"We have him on dialysis right now, and he is going to need a kidney transplant."
Dr. Katie folded her hands,
"There are a few options, there is always the possibility of getting him a donor kidney or equally possible and more... Advisable would be to have a kidney grown for him using his own stem cells, that way we can grow him one like the one he lost, considering there is no way for us to give him two. If he were to get a donor kidney, he would have to undergo chronic gene therapy to avoid medications that would leave him immunocompromised. However, in that case he would need to be medically discharged. If we were to grow him a new kidney, he would be able to return to his post without being discharged, but the cost is... Admittedly much higher."
The family glanced between each other their faces pulled into grimaces.
Adam knew their financial situation. He had heard stories about Ramirez growing up and knew enough to know that his family had never been well off. They had been close, his childhood had been excellent, but they had never been rich. Affording either of those options was going to be a stretch.
"Well, we will have to talk about-"
”Grow the kidney!”
”What?”
"I'll pay for it."
The entire room turned to look at him.
"You-"
"I said I will pay for it. With the settlement for the court case, and/or the amount of money I get from my job I can pay for it. He saved my life this is the least I can do, please..."
His pleading was so plaintive that the family could hardly say no. He did have a point as well. Instead, he received an enthusiastic hug from Ramirez's younger sister who clasped her arms around him and nearly snapped him in half with her strength. She was an olympic boxer after all, so he wasn't surprised.
"Thank you thank you thank you!”
Dr. Katie looked at him with a pointed expression, but she didn't need to ask. He intended to pay for every last cent of Ramirez's treatment even if he had to fight his abuela for it. He wasn't entirely sure he'd win against her, but he would damn sure try if it meant doing something for his friend.
He owed him after all.
And even if he didn't Ramirez was his best friend. This wasn't about owing him, this was about doing anything for someone he cared about.
Dr. Krill shifted in his place,
"We will get the equipment ready and start later this week. I... would be honored to perform the operation. I will be upfront with you and say that I am the universe's foremost surgeon, but I would also be the first Alien to perform an organ transplant."
"I of course, you saved his life last night-"
They seemed almost in shock. Everything was being paid for and the universe most renowned surgeon was practically begging to do it.
The only way this could have been better is if their son hadn't been shot in the first place.
[…]
The steady beeping of the machine echoed around the room. Adam sat with one ankle crossed over a knee looking down at his implant and absently reading through that day's news report as a soft whirring came from the machine just to his right. He wasn't technically supposed to be here, but the doctors had made an exception for him and the family. On the other side of that a glass tube was busy growing an extra kidney. There was security outside the door and a doctor came in every few minutes to check on the kidney, and the man to which the kidney belonged.
Adam scrolled down.
There was a shifting just to his side, and with relief Adam looked up to find Ramirez stirring. The man tried to open his eyes but squinted against the light and groaned raising one IV tethered hand to block the light.
Adam leaned over resting a hand on his arm,
"Hey you're finally awake!"
Ramirez cracked an eye at him and groaned.
*”Oh god…”
”You were trying to cross the border, right? Walked right into that imperial ambush…”
”Urgh… Fuck off!”
"Wakey wakey eggs and bakey! Come on ya freak wake up."
Ramirez closed his eyes again,
"Why... When I wake up do I have to see your ugly ass!?”
Adam snorted,
"How sweet, freak."
”Oh sweet? Ill show you how sweet I can be…”
”Id like to see you try freak.”
"Freak? Have you looked at yourself lately?”
"At least I was born with all my kidneys."
Ramirez opened his eyes and frowned,
"What? Now I can’t follow…"
Adam smiled slightly,
"Turns out your dumbass has lived his entire life with only one kidney. Congratulations, you are a freak of nature."
"No shit, really? I had no idea."
"Oh, trust me neither had Krill, so the next Omen deployment will have to be scheduled a week later, since EVERYONE on the ship will now go through extensive tests to check if they have the right number of organs in the right sizes at the right places… All because of your single fat kidney… anyway the bullet sort of ruined it, when it penetrated you.”*
”Kinky.”
”Sigh…so yeah… you have to get a new one. Or you’re dead.”
He pointed across the room to the glass tube and its slowly growing kidney which was no bigger than a jellybean right at that moment.
Ramirez looked and frowned,
"Ew, gross... wait… who's paying for that, because I don't think the military covers transplants."
"It's taken care of."
"By who?"
"By someone."
"Someone who?"
"Someone who would rather remain unnamed."
Ramirez looked at him,
"It's you isn't it?”
”Maybe…”
”Awwww… you do love me after all! As a thank you I am sure I have something for you in pants as well, wink wink.”
”I hate you sometimes.”
”For real though, isn’t that too expensive?”
Adam sighed,
"You saved my life, so shut up and just let me buy you a new kidney. I owe you that much at least."
"Fine, fine."
There was a pause between them.
"I... thank you, for saving my-"
"Dude don't get all sappy and shit on me ok? You would have done it for me."
Adam went quiet, still wishing to thank his friend but knowing Ramirez would never accept it.
”As much as I like your company, why are you alone here? Is no one else caring that I’m hurt? Where is Mav? Where is my family?”
”Since you are stable your family went to a hotel close to the hospital, they should be here tomorrow morning again. As for Mav she went back to the ship and has shut herself into the chapel apparently, bit weird, but you know her, she doesn’t like earth much. Why you asking?”
Ramirez shifted to look at him,
"I need to kick her lazy ass for not being fast enough, because of her I had to jump in to save your sorry ass and paid with my kidney for it. Soooo uhhh, you know why they tried to kill you?"
Adam shrugged,
"Not really, the lady who did it has some political affiliations who don't tend to agree with me, but that connection doesn't seem to fit completely. Either that or she blames me for making her son an extrial in which case... That hardly makes sense either."
He shrugged,
"Either way she isn't talking, and now I can't go anywhere without five to six bodyguards spilling out my ass."
Ramirez snorted, eyes closing, breathing deeply.
"You feeling ok?"
"Yeah... I'm alright, just tired."
"Then go back to sleep ya big idiot. Maybe if you're a good boy santa will leave a kidney under your pillow."
Ramirez let off a weak huff,
"Didn't know santa was a black market organ dealer."
"Hey, this is christmas, now shut up and go to sleep."
Ramirez didn't argue with him beyond that point, and fell back asleep just as a nurse was coming to check on him.
Adam was relieved.
Ramirez was, hopefully, going to be ok.
Though what remained were far more questions than there were answers.
Previous First Next
Want to find a specific one, see the whole list or check fanart?
Here is the link to the master-post.
Intro post by me
OC-whole collection
Patreon of the author
Thanks for reading! As you saw in the title, this is a cross posted story written by starrfallknightrise and I'll just upload some of it here for you guys, if you are interested and want to read ahead, the original story-collection can be found on tumblr or wattpad to read for free. (link above this text under "OC:..." ) It is the Empyrean Iris story collection by starfallknightrise. Also, if you want to know more about the story collection i made an intro post about it, so feel free to check that out to see what other great characters to look forward to! (Link also above this text). I have no affiliations to the author; just thought I’d share some of the great stories you might enjoy a lot!
Obviously, I have Charlie’s permission to post this and for the people already knowing the stories, or starting to read them: If you follow the link and check out the story you will see some differences. I made some small (non-artistic) changes, mainly correcting writing mistakes, pronoun correction and some small additional info here and there of things which were not thought of/forgotten or even were added/changed in later stories (like the “USS->UNSC” prefix of Stabby, Chalar=/->Sunny etc). As well as some "biggemajor" changes in descriptions and info’s for the same stringency/continuity reason. That can be explained by the story collection being, well a story collection at the start with many standalone-stories just starring the same people, but later on it gets more to a stringent storyline with backstories and throwbacks. (For example Adam Vir has some HEAVY scars over his body, following his bones, which were not really talked about up till half the collection, where it says it covers his whole body and you find out via backflash that he had them the whole time and how he got them, they just weren't mentioned before. However, I would think a doctor would at least see these scars before that, especially since he gets analyzed, treated and goes shirtless/in T-shirts in some stories). So TLDR: Writing and some descriptions are slightly changed, with full OK from the author, since he himself did not bother to correct these things before.
submitted by maximusaemilius to HFY [link] [comments]


2023.12.06 03:55 jhxixxii Gene Editing and Human Advances in a Christian Worldview

My audience is every person who is willing to read about genetic editing and human advances from a Christian worldview. The purpose of writing this is to inform any fellow readers about how genetic editing, human advancement, or trans-humism is against the word of God and makes a mockery out of the Bible.
To understand exactly what gene editing and human advancement are from a Christian worldview, we first must look at what God thinks about human editing. In the Bible, from the book of Genesis to Revelation, there are 58 verses that talk about our body and how God created us. While the Bible doesn’t exactly talk about gene editing or human advancements, by looking at and understanding the context of each verse, we are able to decipher that humans are not meant to be changed in the field of genetics because we were already created perfectly by the perfect creator.
1 Corinthians 15:38-39 ESV says,
“But God gives it a body as he has chosen, and to each kind of seed its own body. For not all flesh is the same, but there is one kind for humans, another for animals, another for birds, and another for fish.”
Our bodies are not designed to turn into anything else other than it’s ownself. Meaning that we are meant to be who we are meant to be. In today’s world, we can see that governments, big pharma companies, and radicalized organizations like the World Economic Forum are in support of advancing living organisms such as humans, animals, and plants genetically to “save the world.” But what is gene editing exactly? Gene editing is a method that lets scientists change the DNA of many organisms, including plants, bacteria, and animals. Editing DNA can lead to changes in physical traits like eye color and disease risk (NHGRI, 2019). In theory, if you can change the outcome of your physical appearance, change the way you have children, or change the way your body can no longer be sick, that would sound amazing. However, you could be destroying yourself in the way our species is supposed to live.
In general, the evolutionary theory of the socio-political transhuminist movement centers on genetic editing. To put it succinctly, the transhumanist movement aims to develop and apply technology in a way that will fundamentally alter humanity beyond its current physiology and limitations. This includes enhancing or amplifying innate abilities like intelligence and physical strength, creating bodies resistant to disease, extending lifespans, or preventing death entirely. Through genetic editing, radical companies, researchers, and scientists want to create the “ulitamate” being to lead the world into a new world where humans are now the rulers of the Earth instead of God.
Throughout the many years, conservative scientists, military generals, politicians, C.E.O.’s and many others have questioned the ethics of gene editing for quite some time, just like the United States Director of National Intelligence, James Clapper, addressed the threat of gene editing as a weapon of mass destruction (Regalado, 2016). However, on the eastern side of the world, contraversial billionaire Professor Karl Schwab, who wrote a book called The Fourth Industrial Revolution, talked and wrote about changing the human race genetically and how humans need to adapt to the change in the world. However, Karl Schwab is also the same man who is in favor of wanting humans to eat bugs instead of eating real meat (except for himself) (Hubert, 2021).
In most countries, genetic editing is illegal. But not human advancement. Gene editing, however, is not banned in the United States; a moratorium is imposed under the vigilance of the Food and Drug Administration (FDA) and the guidelines of the National Institutes of Health (NIH) (Lui, 2020). And the reason why most countries ban genetic editing is because of reports of unethical practices that are potentially dangerous and could lead to a new era of eugenics (Global Gene Editing Regulation Tracker, 2019). But for human advancement, it’s a totally different story because human advancement could mean plastic surgery or cybernetic replacement.
There is a lot of scientific data that shows the effects of genetic editing. In one study, a Chinese researcher named Doctor Jiankui He created two sets of twin girls with HIV/AIDS resistance genes. Which would realistically sound like a great gene to have. However, Doctor He and two collaborators forged ethical review documents and misled doctors into unknowingly implanting gene-edited embryos into the woman who had the children (Greely, 2019). There is no further data on the children or if they are positive for resistance against HIV/AIDS. But Dr. He and his associates did go to jail for three years because of their ethical wrongdoing. Yet, there is no available data to support a Christian worldview on genetic editing. However, it is important to understand that genetic editing is not to be played with. In the year 2020, a group of researchers led by biologist Kathy Niakan and her colleagues at the Francis Crick Institute set out to better understand the role of a specific gene in the early stages of human development. They used CRISPR (a genetic editing tool) to remove that gene from human embryos donated for research. When they analyzed the edited embryos and compared them to unaltered embryos, they discovered something troubling: Approximately half of the edited embryos had significant unintended changes. Which would mean if the child was born, they would have extreme birth defects or extreme genetic disease (Mullins, 2021). The scientist had to exterminate the embryos after 14 days of discovery. Because scientists are always looking for ways to create the kinds of creatures or humans they want, they generally have a low sense of ethical responsibility.
And because of these researchers, doctors, and institutes, governments are regulating or restricting more and more because this type of science is unnatural and unethical. In a sense, these researchers are playing “God.” And governments are truly trying to stop it.
As it was said before, this is not the first time the topic of genetic engineering has been discussed. The question of gene editing or human advancements has been around for roughly a generation. The realization of gene editing technology was supposedly discovered in the 1900s’ (NHGRI, 2019). However, if we go through history, we see that there was a group of people called the Nephilim. These people were considered "giants.” But not just any giants; they were half humans and half fallen angels. Thus being considered the first genetically modified people in the entire world until the great flood destroyed the bloodline as it was described in the book of Genesis. Even the people called the Philistines had people like the giant Goliath, who were over 9 feet tall and claimed to be a more advanced race of people. But the question of gene editing was around before the discovery of genetics. In 1962, a group of farmers in northern Israel discovered a horad of spear heads that ranged anywhere from 13 inches to 26 inches (Hestrin and Tadmor, 1963). Roughly an average-sized spear head during Samuel and David's time would be estimated at two to four inches at most. But if we look at 2 Samuel 21:16 ESV, the scripture says,
“Ishbi-benob was a descendant of the giants; his bronze spearhead weighed more than seven pounds, and he was armed with a new sword. He had cornered David and was about to kill him.”
A two- to four-inch spear would not weigh nearly half a pound. But a forged bronze spear head that weighed more than seven pounds would have to belong to a giant.
Most societies other than the United States care and don’t care much about the issue. China and Japan are the most known to be openly against genetic editing. Western societies, however, are more open to the idea. As we see in our society today, everything and anything goes for people because life is about “feeling” in western societies. However, for society to work together and solve the issue of banning gene editing, it must first have a strong leader. Second, we must have strong voices that speak the truth; arguing with other people will never get anyone anywhere. And third, we have to stop letting people who want anarchy have what they want; we have to put them in their “place.” And there “place” is the back seat, where they contribute nothing except how to do everything. But overall, society has to put personal agendas aside to work together to understand that the evil in the world will never overcome the light of the world.
Artistically, there are famous pieces that show DNA in the forums of snakes or serpents, just like the serpent in the Garden of Eden that destroyed the first connection between God and man. Artist Pete Renolds created a picture of a snake being tranced with music and there is DNA missing (Li, 2021). In a way, it is like the serpent in the Garden of Eden being tricked by humans to take its DNA for other people. Just like the Nephilim. But there are a lot more pieces of art that have the same meaning. Artists like Dan Mitchell, Alashi, and many other famous artists are also against gene editing and human modification. And what other aspiring artists can do is create art that starts the discussion and encourages people to start asking questions about the true meaning of life and how God wants us to live according to his way and his will.
Scripture says in Psalm 139:13-14 ESV,
“For it was you who formed my inward parts; you knit me together in my mother’s womb. I praise you, for I am fearfully and wonderfully made.Wonderful are your works that I know very well.”
Genesis 1:26-27 ESV says,
“Then God said, “Let us make humans in our image, according to our likeness, and let them have dominion over the fish of the sea and over the birds of the air and over the cattle and over all the wild animals of the earth and over every creeping thing that creeps upon the earth.So God created humans in his image; in the image of God, he created them; male and female, he created them.”
Again, overall, there are 58 verses in scripture that talk about our body and how God created us. While the Bible doesn’t exactly talk about gene editing or human advancements, by looking at and understanding the context of each verse, we are able to decipher that humans are not meant to be changed in the field of genetics because we were already created perfectly by the perfect creator.
And when we use the Bible for finding truth, we are able to use Biblical truth and God’s engagement by using the Holy Spirit. By using the Holy Spirit, we allow the presence of God to infiltrate the release of truth from the lies we receive from the world. And as we go through scripture, we see that God always infiltrates the bad in the world to bring outcomes that are good. As we saw in Genesis of the Great Flood, scripture tells us that the reason behind the flooding of the earth is not because of sin and wickedness. It’s the result that comes from sin and wickedness. And the result was that people became wicked by having children with demons, creating half-humans and half-demons. Which makes them not entirely human. But as long as we stay engaged with God like Noah was, we will be able to speak clearly on the issue.
How might the church and Christian stewards solve this problem faithfully? The church and Christian stewards can solve this issue first and foremost by coming to an agreement that gene editing and human advancement go against the will and commandments of God. Now, it doesn’t have to take a church to realize that the issue has to be agreed upon. It only takes the Holy Spirit to realize that the issue can be solved. Because without the Holy Spirit, how will we be able to understand that editing the human parts of a human is wrong in the eyes of God? As Christians, we have to understand that there is power in the words we use and in the name of Jesus alone. Without understanding both of those concepts, we are lost when we go against the evils in the world.
There is a solution to the problem of stopping gene editing. The solution is far more simple than it could be imagined. The solution is to simply speak up and speak out to the world about the dangers of genetic engineering and human advancement. Genetic editing and human advancements are a danger and a sickness to society itself. It acts as a threat to the world, threatening the image of the human species in the form of a religious and scientific matter. And as most governments in the world agree, genetic editing should not be allowed because of the threat it can pose. Even as we see in pop culture today in movies, books, and videogames, people fantasize of a world that is less human and more cybernetic and diverse through the evolution process of changing our genes. But if we speak up and speak against the people and perpetrators of going against God’s image of humans, plants, and animals, then we would be able to fully stop them in the tracks of creating a world just like the day's of Noah.
Bibliography
Gene-Editing. “United States: Germline / Embryonic.” Global Gene Editing Regulation Tracker, July 23, 2019. https://crispr-gene-editing-regs-tracker.geneticliteracyproject.org/united-states-embryonic-germline-gene-editing/#:~:text=Most%20US%20faith%20groups%20and,a%20new%20era%20of%20eugenics.
Greely, Henry T. “CRISPR’d Babies: Human Germline Genome Editing in the ‘He Jiankui Affair.’” Journal of Law and the Biosciences 6, no. 1 (August 13, 2019): 111–83. https://doi.org/10.1093/jlb/lsz010.
HESTRIN, RUTH, and MIRIAM TADMOR. “A Hoard of Tools and Weapons from Kfar Monash.” Israel Exploration Journal 13, no. 4 (1963): 265–88. https://doi.org/10.2307/27924950.
Hubert, Antoine. “Why We Need to Give Insects the Role They Deserve in Our Food Systems.” World Economic Forum, July 12, 2021. https://www.weforum.org/agenda/2021/07/why-we-need-to-give-insects-the-role-they-deserve-in-our-food-systems/.
Li, Gege. “CRISPR Gene-Editing Urgently Needs an off-Switch – Now We Have One.” New Scientist, January 13, 2021.
Liu, Shuang. “Legal Reflections on the Case of Genome-Edited Babies.” Global Health Research and Policy 5, no. 1 (May 14, 2020): 1–3.
NHGRI. “What Is Genome Editing?” Genome.gov, March 13, 2019. https://www.genome.gov/about-genomics/policy-issues/what-is-Genome-Editing.
Mullin, Emily. “Scientists Edited Human Embryos in the Lab, and It Was a Disaster.”, January 26, 2021. https://onezero.medium.com/scientists-edited-human-embryos-in-the-lab-and-it-was-a-disaster-9473918d769d.
submitted by jhxixxii to u/jhxixxii [link] [comments]


2023.12.03 06:43 moldybreadclub mopping after ammonia based cleaner

mopping after ammonia based cleaner
i just cleaned with an an amonia based cleaner and it left a residue on the floor, i was gonna mop anyways but are these two okay to combine ?
submitted by moldybreadclub to CleaningTips [link] [comments]


2023.11.18 08:04 nomorelandfills The Emily Ruckle attack, part III - The Final Surgery

The Emily Ruckle attack, part III - The Final Surgery

https://preview.redd.it/ns1ki1dy021c1.png?width=698&format=png&auto=webp&s=fc5bfae30958dbe24b1beaa4edfa9038aaeaeabc
Emily Ruckle arrived at Children’s Hospital of Philadelphia clutching root-beer flavored Chapstick.
Two years after a pit bull nearly severed her right arm during an attack in the family home, the 10-year-old braced for her 12th surgery. She would smear Chapstick on the anesthesia mask to hide the dreaded medicine-like smell she associates with surgery.
"You know you're a frequent flier when you bring your own chapstick," her mother, Maria Ruckle of Newark joked as the family waited in the surgical suite.
Doctors hoped this procedure would give Emily more mobility, more dexterity. She couldn't lift her right arm over her head, make a fist with her right hand or grasp her cell phone with her right hand. Picking up whisper-thin pieces of a board game required so much concentration her face burned red with exertion.
Still, Emily did not want to endure another surgery. And she made the case that her arm worked fine, that 11 prior surgeries had saved her arm and repaired enough nerve damage to give her a normal life. She worried it might go wrong.
"They said maybe it will mess with the nerves and it might, like, hurt me," Emily explained in the weeks before returning to CHOP for the final surgery. "So I don’t want any chances of it."
Earlier in the summer, plastic surgeon Ines Lin gently moved the fingers on Emily's right hand to show her and her parents how all four would bend in unison if a tendon transfer surgery was successful. Tendons are strong connective tissues that attach muscles to bone.
In a tendon transfer, surgeons take a working tendon and attach it to tendons and muscles that have nerve damage. Over time the attached tendons fuse together, giving a patient more motion.
In Emily’s case, the tendons would be taken from her right arm.
Securing movement in the thumb would be more complicated, Lin said, but with luck and physical therapy, Emily had a realistic chance of using her right hand to grab and hold objects.
Emily stared into space and brought her legs up to her face. She bit her knees as her parents agreed to the surgery on Aug. 19, one week before Emily started fifth grade.
Todd and Maria Ruckle were certain they had made the right decision. One was the best chance Emily had to be able to use her right hand after the attack.
The day of surgery, nurses applied root-beer Chapstick to Emily's anesthesia mask. But it didn't do its magic this time, and Emily began to panic and cry as the anesthesiologist covered her face.
"Nice, deep, breathing," the anesthesiologist cooed. He removed the tube through which the medicine was applied.
“See?” he said, again placing the mask over her face. Emily relaxed. Then he attached the tube.
Deep breath, he said, "just like a dive in the pool."
Emily's eyes fluttered and slowly closed. She’s asleep. Again.
One month earlier, on a sweltering day in July, Emily, already sunburned from too much time at Wildwood, New Jersey, turned bright red at A.I. duPont Hospital for Children in Wilmington.
She scrunched her nose and squinted her eyes as she willed her left hand to grip a small game board piece and drop it in a tray. It was as if the piece, about the size of a quarter, weighed 100 pounds.
Emily’s first 11 surgeries left a build-up of scar tissue in her shoulder, which is stiffer and inhibits movement. Therapists at A.I. carefully massaged her shoulder and arm to break up that scar tissue. And martial arts classes helped train both sides of her body, strengthening both arms equally.
Therapist Tracy Shank worked with Emily on reawakening nerve impulses by having her do everyday activities such as tying shoes. Shank rubbed a green pom-pom and materials on Emily's right hand to see if she could feel the sensation. Some worked, others did not.
Emily has fearlessly stared down her injuries. One day, she did somersaults on the exam room table, careful that her arms did not touch the table. Another day, as her mom helped her get dressed for Taekwondo, Emily announced to her parents: “I can sort of do a cartwheel.”
They smiled nervously in response, happy that Emily's childlike zest for life was returning. But they did not want Emily's energy to cause an unintended injury.
"More time has to pass before we let the daredevil in her to come back out," Todd said.
Casual observers see little evidence of trauma in Emily. Since the mauling, she’s gone from 59 pounds to 83 and sprouted long, limber legs and sinewy arms that help her bend, twist and spin through the day.
The attack did nothing to dim her infectious personality and determination. Emily is not phased by the word "no" from her parents, and uses her rehabilitated arm to hug her mother extremely tight and poke her dad in the stomach.
The fifth-grader is not afraid to wear a bathing suit or pose for pictures with her family. Her biggest challenge, she said, is making it through common core math.
The horror of the attack made Emily's parents realize how fragile life is, and they pushed to create new family memories. They’ve taken Emily on cruises, to Disney World, to the Poconos and to Rome and Turkey – a recent trip inspired by her love of the Magic Tree House novel "Vacation Under the Volcano." Hawaii is now on the radar.
Emily has become comfortable again around most dogs, including those in her home. She remains uneasy about pit bulls, although therapy has helped. At the University of Delaware’s Ag Day in April, Maria was shocked to watch Emily pet a pit bull.
Her parents aren't so trusting of pit bulls. They advocate for stronger animal control laws such as mandatory insurance for dog owners. After the attack, the Ruckles received letters from pit bull advocates, Maria says. One wrote that her daughter should have been shot instead of the dog.
The last surgery
On the morning of the 12th surgery, Todd proved to be a good distraction as the family waited for Lin: He split his shorts along a seam in the crotch. Emily gave him the eye and collapsed in laughter on the gurney.
"It didn't fully rip," Todd groused, looking down at his khakis.
Emily cradled an iPhone in her injured right hand, her index finger and thumb fixed in a straight position. Because of nerve damage, the fingers would not curl over the phone to fully grip it.
Emily talked nonstop and played games on her phone to ease her nerves. Freddy, a new stuffed friend won at Wildwood, sat next to her.
She would not be getting "giggle juice," a medicine given to kids to help them relax before going into the operating room, Emily announced. The taste reminded her of spoiled bubblegum mixed with vomit, she said.
Lin appeared in baby blue scrubs, her engagement and wedding bands on a chain around her neck, and she tried to calm Emily’s nerves.
"How are you doing?" Lin asked, grabbing Emily’s left hand and holding on. This would be Lin's second surgery of the day.
"I'm scared," Emily said. Dressed in royal blue soft cotton pants and a short-sleeved pullover printed with pictures of planets, Emily's eyes looked glassy as Lin explained the surgery – one more time.
Lin stamped Emily’s right hand with a red X and placed that hand over a white blanket so she can intently study it. In addition to the tendon transfer, Lin planned to work on scar tissue to make it look better.
Emily played with Freddy, rubbing his cheeks as Lin finished debriefing the family. Nurse Nicole Peck wheeled Emily to the operating room as her parents reached for one more hug, Maria burrowing into Emily's face.
"I'll be here when you wake up," Maria said.
The operating room smelled like Clorox, and Emily’s mood suddenly changed. Her pupils grew wide as she eyed the pile of scalpels and scissors. She looked around, the apprehension in her face apparent.
Someone shouted out that Emily was allergic to adhesives. Nurses draped a warm blanket over Emily then belted her to the stretcher.
After Emily was sedated, music mixed with the beep, beep, beep of the heart monitor and other machinery.
"Treat You Better" by Canadian pop idol Shawn Mendes crackled to life through the streaming Pandora station. Nurses propped up Emily with yellow foam rollers and placed another layer of blankets over her.
"Freddy gets a mask," Lin said, even though Emily isn’t awake to see it. He would also be fitted with a red cast on his right arm, just like Emily.
At 9:24 a.m., Lin injected a steroid into scars on Emily’s left shoulder to soothe inflammation and smooth the wound. She also cut into a small scar on the outside of her forearm so it could be resown, improving its appearance.
Lin examined a six-inch silver raised scar on Emily’s right forearm, and marked it. This would be the entry point for surgery.
The doctor's cut revealed yellow fat, muscles and tendons, remarkably like a picture out an anatomy textbook. Using glasses with microscopes fitted over the lens, Lin poked through tissue in search of working tendons. She pressed on tendons to determine which would respond to stimuli.
Lin tied nerves with blue string as a marker. She found the tendon attached to the index finger and moved it so she could sew it to tendons connected to muscle that fires the middle, ring and pinky fingers.
If this procedure worked, Emily would be able to bend her fingers and make a fist. All fingers would move together. Lin pressed on the recently tied tendon and the fingers moved in unison – like a scene from a Frankenstein movie.
The thumb was up next. Lin made a small incision near the outside of Emily's wrist and sewed the thumb tendon to another that controls the elbow and wrist. These tendons help the thumb curl into the palm.
Ninety minutes into the surgery, the tendons had been fully transferred and the wounds were cauterized to control blood flow. Emily had five new sutures on her arm and a fiberglass cast that prevented her from moving her elbow, wrist or fingers.
The had to stay on for at least a month, then Emily would need a splint and light physical therapy.
"She's a tough cookie," Maria said when Lin warned them that Emily would be sore following surgery.
When Maria and Todd were permitted to see Emily, she was out of it, in pain and angry. She told her parents, again, that she was happy with the way her arm was before.
And she demanded a watermelon Popsicle. A nurse suggested cherry.
"I don't like cherry," Emily wailed, overreacting in the fog of anesthesia. By 3:15 p.m. that afternoon, the family was back home in Newark.
The next day Emily ached, but she refused pain pills. She asked her dad to wear a matching red cast, which he made at home and happily attached to his arm.
Emily's cast was scheduled to come off on Sept. 14, so the family snuck away to their cabin in the Poconos for Labor Day.
When they returned, school was in full swing. Megan, Emily’s half-sister who was with her when the pit bull attacked, had already begun her senior year at Newark Charter.
Megan is considering a career in medicine and has looked at colleges outside of Delaware. But she may choose the University of Delaware because it’s close to home and Philadelphia’s medical schools. Plus, she reasoned, if she chose UD, Emily could occasionally spend the night at her dorm.
The sisters have become closer since the attack, and routinely hop between each other’s bedrooms at home.
“I know that I did a good job because Emily doesn’t harbor any bad feelings,” Megan said. “Even though I always feel responsible, but I know Emily’s not upset about it.”
Neither likes to talk about the attack and they rarely bring it up. So Megan was surprised when, on a late-night drive to Wawa before that final surgery, Emily nonchalantly asked: "Where were we going on that walk before I was attacked by the dog?"
The girls have relived bits of the bloody episode through a sister shorthand of musings and sometimes off-hand comments.
"That's how I deal with it," said Megan, now 17. "I just talk to Emily. She's really the only one who knows exactly what happened."
On Sept. 14, Emily is back on an exam table at CHOP. This time, she’s dressed in her Newark Charter uniform: a light pink polo and tan skort, a skirt with shorts attached.
She does not talk about the surgery or the cast. And she clearly does not like the small hand saw a technician used to cut off the cast, which made the room smell like burning glue as layers of gauze are peeled back.
The technician fitted Emily with a white sling and sent the family in an elevator to Lin.
"I can feel my hand," Emily said as she walked the hall. "I've been waiting so long for this to come off."
"You've been waiting four weeks," Maria said in the practiced tone of a parent with a dramatic child.
"It's a long time for a kid, mom," Emily countered.
Todd has fantasized about this moment. Maybe Emily could play field hockey. Or pursue her dream of riding horses.
It would be amazing if she could just grip her iPhone with her right hand.
Lin, too, is excited. She cut off the gauze and instructed Emily to bend her fingers.
Slowly, deliberately Emily willed the fingers to bend. She also curled her elbow and brought her hand to her face. He thumb curled into her palm, just as the surgeon hoped it would.
Maria’s and Todd’s eyes widen and turn glassy. But they don’t cry. They’re proud. Their warrior princess defied odds again.
Lin warned them that Emily will have a slow recovery and need to do specific exercises to ensure movement in her hand. Other than the exercises, Lin said, Emily should not use the hand much.
The trampoline would be forbidden, Todd immediately warned Emily.
Emily slid off the table and walked over to the mirror in Lin's office. She held her arms out in front of her, her hands down by her waist, and compared her arms from different angles.
Scars curled like faded henna tattoos from her upper chest to her armpit to a six-inch wave on her forearm. Skin puckers a bit around her right shoulder.
But her bulging bicep muscle isn’t as pronounced, and her arms looked almost equal in size.
Satisfied, she smiled, then said, "It sort of looks normal again."

https://preview.redd.it/n6nagdy9221c1.png?width=697&format=png&auto=webp&s=78a60825cb48d30683f593ae54e029f62ed360e1
submitted by nomorelandfills to BanPitBulls [link] [comments]


2023.11.18 07:55 nomorelandfills The Emily Ruckle attack in Delaware - part II, The Hospital (2014) very comprehensive newspaper piece from 2016, tracking the attack and the efforts to save the victim's arm

The Emily Ruckle attack in Delaware - part II, The Hospital (2014) very comprehensive newspaper piece from 2016, tracking the attack and the efforts to save the victim's arm

https://preview.redd.it/qssdfeibz11c1.png?width=708&format=png&auto=webp&s=31956ae575da69c813941902ef84d6cada0f9301
Todd Ruckle thought he was driving to Philadelphia to pick up his daughter’s body.
He had seen 8-year-old Emily as she was being loaded into a helicopter at A.I. duPont Hospital for Children in Rockland to go to the Children’s Hospital of Philadelphia. Her skin had turned yellow and clammy, and all he could think about was a corpse in a casket.
An hour earlier, Emily had been attacked by a 100-pound pit bull named Frank that lived with her half-brother in the family’s Newark home. Her right arm was left hanging by a strip of flesh, and she bled profusely.
A.I. immediately transferred her to Children's Hospital of Philadelphia.
Emily’s parents, Todd and Maria Ruckle, were stunned to learn their child had been savagely attacked while they attended a wedding. Drowning in guilt, they screamed at each other while speeding along I-95, searching for directions to CHOP on their smartphones.
Word spread fast about the attack, and family and friends peppered their cellphones with inquiries about Emily. Each ring turned off the GPS, and they got off at the wrong exit in Philadelphia.
"It was just pure chaos," Maria said of Saturday, Sept. 27, 2014.
Finally around 3:30 p.m., two and a half hours after Emily was horribly mauled, Todd and Maria rushed into CHOP's surgical waiting area still dressed for the wedding —Todd in a tuxedo, Maria in a sparkly red dress.
Emily was already in surgery. Her sister, Megan, who had been with Emily when the dog attacked, had left A.I. duPont Hospital and was now at a friend’s house in Newark. Maria's son Jack had met them at A.I. duPont when Emily arrived, but he returned home to clean up his room and throw out his mattress, covered in Emily's blood.
Todd sat by his parents in CHOP's surgical waiting room. He blamed his wife for bringing the dog into their home. He blamed himself for not being able to protect Emily.
He and Maria sat on opposite sides of the waiting room slumped over in chairs, their cellphone batteries now dead.
"He wouldn’t even speak to me," Maria said. "I sat in that waiting room by myself."
Todd doesn’t remember it being that dramatic. He said he sat by a computer so he could have contact with the outside world.
On television, Todd and Maria could see Philadelphia news stations airing reports about the attack. On the screen appeared a picture of their home, cordoned off with yellow crime tape. Maria's ex-husband was interviewed about his pit bull named Frank, which two months earlier came to live with the Ruckles when the ex moved out of town.
Anxious waiting stretched into the evening. Todd stripped down to an undershirt, and Maria kicked off her heels.
Every two hours they got updates from Emily's surgical team. Late in the evening they were told that Emily would survive, but her arm might not be salvageable.
Todd and Maria took to Facebook to keep family and friends informed:
Todd, 5:20 p.m. Sept. 27, 2014: My daughter is alive and will survive. She has 4 to 6 hours of surgery with three different teams of surgeons. We are praying we can save her arm. I am truly in need of love and support. Please send every ounce of positive thoughts right now.
Dr. Ines Lin, a reconstructive and plastic surgeon, was at her Bryn Mawr home 30 minutes from CHOP when she got an emergency call about a bad dog bite to a child's upper arm.
Lin, who was eight and a half months' pregnant on the day of the attack, raced to the hospital.
"This is by far the worse one I have ever seen," she said.
Lin usually talks to the family before operating. But with Emily's life imperiled, there was no time.
Dr. Joy Collins, a trauma surgeon at CHOP, led the team of doctors and nurses that prepped the 8-year-old, wrapping the wounds in gauze. Two IVs were placed in Emily's left arm because the right arm couldn't support an intravenous line. The team's top priority was ensuring that Emily was breathing and able to survive the surgery.
“We were worried about blood loss,” Collins said.
Emily was assessed for rabies and given a shot to ward off infection. By the time Lin saw Emily, orthopedic surgeons had pinned her fracture together with two bolts — but the arm was a cool, light blue color, indicating a lack of blood flow.
Lin had to act quickly or Emily would lose her arm.
A complete amputation is easier to reattach because doctors can cool the extremity. Cooling prevents tissue damage and gives surgeons more time to operate.
When a severely damaged limb is still on the body, it’s more challenging to maintain blood flow. If muscles and nerves don’t get blood flow within six to eight hours of a major trauma, tissue could die. And even the most delicate surgical movements can harm existing vessels and tissue.
Lin was worried.
"There were definitely times I wasn’t sure we were going to do it," she said.
Out in the waiting room, Todd and Maria had finally stopped slinging recriminations at one another. Their daughter would live, and they knew they needed to be a team for their little girl. At midnight, Emily was still in surgery.
Todd, 12:10 a.m. Sept. 28, 2014: We are waiting patiently. Thank you again for all your prayers.
Doctors had to cut through muscle and tissue to find Emily’s brachial artery, located near the armpit and feeds the arm and hand. When they finally found it, they realized part of it had been shredded and was dark red — a sign of clotting.
To keep blood flowing, doctors tried twice to hook a 12- to 14-centimeter vein from Emily's right thigh to the artery in her arm to rebuild the area damaged by clots. Using a microscope Lin and her team made small sutures, or stitches, about as thin as a strand of hair to sew the vein to the artery. The second time took.
Lin also performed a fasciotomy, a procedure that involved cutting tissue and skin surrounding the arm muscles to allow swelling. That way the muscles would not be restricted when the blood began to flow again.
The surgeon can't remember precisely when, but Emily's arm gradually moved from blue to pink, a sign the blood was flowing.
Yet that created another problem. To stop the clotting the team gave Emily blood thinners. Now the side effect was excessive bleeding, which had to be contained.
An 8-year-old's body contains only about 2.3 liters of blood, less than a gallon of milk. But during surgery Emily lost 8 liters of donated blood, meaning she essentially bled out four times in the first 12 hours after the dog attacked.
To Todd, it seemed like everything went wrong. But finally they got good news.
Todd, 2:16 a.m., Sept. 28, 2014: Emily has two more hours in surgery. She will not lose her arm, however, she will most likely losemost use of it. In time and a few more surgeries she may have some movement. I am beyond happy she is alive and I hope to see her soon.
Surgery finally ended around 4:15 a.m. — 13 hours after the dog attacked. But no one was celebrating.
Todd, 7:24 p.m., Sept. 28, 2014: Tonight is the critical night. There are issues with fluid in her lungs from all the blood transfusions. Her heart rate isalso too high. She continues to be in a medical coma. They are still picking up a heartbeat in her hand which is good news. If she has no issues tonight she will be going through a second surgery tomorrow morning.
When Todd and Maria saw Emily, her face was swollen and bloated, her brown eyes shut. She was hooked up to nine machines including a ventilator, respirator and feeding tube. Her chest thumped so violently it looked like her beating heart could crack her ribs.
White gauze was draped over her arms, shielding most of the surgeons' work. Metal rods stuck out of her right arm in open cuts still fresh with blood.
Maria held her little girl's hand while the couple prayed. Maria stayed up all night watching the pulsometer register Emily's blood pressure, anxiously breathing when the numbers dropped.
Emily didn’t open her eyes until dinner time two days after the attack, when she heard her brother Jack's voice.
Maria, 6:34 p.m., Sept. 29, 2014: She's responding by nodding and shaking her head. So happy!
Todd dreaded what Emily would say when she could talk. He expected her to feel guilty because she knew he did not like her handling Frank.
Still struggling to breathe, she said softly and slowly, drawing out each word, "Daddy, I'm so scared. And I'm so ... sorry."
"I lost it," Todd said. "I couldn't stop crying."
The couple didn't leave the hospital for days. Friends brought toothpaste, shampoo and food. Three days later, friends finally convinced Maria to get out of her sparkly dress and into the shower. Her son Jack had hurriedly grabbed clean clothes, for which Maria was grateful.
"But I'm in sweat pants and a thong," she recalled. "I told him next time, 'Grab the granny panties, please.'"
During the first seven days in October, Emily was in and out of the operating room for three surgeries and to have her wounds cleaned to prevent infection.
Maria, 7 a.m., Oct. 1, 2014: Overnight her temperature dropped — we had to put her in a warmer — but it could be a sign of infection. Won't know for about 24 hours until the cultures come back. She's much more responsive, but she's getting worked up about wanting to go home, not wanting to miss school and she's thrashing.
Todd, 5:17 p.m., Oct. 1, 2014: Emily is coming in and out of consciousness. She wakes up and she does not know where she is. We explained about 50 times where she is and she says how scared she is. She said she feels trapped in a house. She still cannot breathe on her own.
Todd, 8:32 p.m., Oct. 1, 2014: By the end of the night I figured out that she is reliving the attack. She keeps screaming I do not want to die. I am no longer me. All we can do is tell her she is safe and we love her.
Intravenous lines were placed on the top of Emily’s feet and the top of her hands, and she screamed every time the lines were changed. As she improved, the equipment she had been tethered to was removed.
But her damaged right hand began to spasm, prompting fits of screaming.
Maria, 10:21 p.m., Oct. 6, 2014: I have never felt more helpless in my life
Yet, at times, Emily was still Emily. She could still beat her dad in a game of Go Fish. She demanded a cheeseburger or chicken sandwich and a vanilla Frosty with fries.
By Oct. 7, Emily was well enough to move to CHOP's fourth floor in a private room with a cot and bathroom. Mom and Dad took turns spending the night on the cot.
The Ruckles made friends with the family of a little girl down the hall, who also was in for a long stay. She lived with a congenital condition that caused deformities in her chest. Maria and her mother would walk the floor or go down to the cafeteria to grab coffee.
Doctors kept Emily pumped with painkillers, resulting in "morphine mumblings," Maria recalled. The little girl thought she was in Minecraft, an online adventure game she adores. She flip-flopped between giggling and having panic attacks. She would screech, "No, no, no, no, no," and then demand, "How do I get out of this room?"
Once Emily looked over and saw Todd sitting by her bedside.
"Dad, you are bouncy," she said. What about her brother Jack, her parents asked. Both men are broad-shouldered and stocky.
She called Jack "Earth," a name that stuck for a while.
Nurses came in hourly to check Emily's vital signs. They equipped her with a Nerf gun so she could shoot the orthopedic resident and sometimes her dad. To get her to take her medicine, another nurse joked she would sit on her if she didn't do as instructed.
Emily's right arm was immobilized in a white sling, with braces on her wrist and elbow and tape on her upper arm and shoulder. Every three days her arm was washed, suctioned and dressed in moist gauze.
Little victories meant a lot. Todd and Maria cheered when Emily could finally sit up on her own.
Megan, Emily's half-sister, occasionally rode the train from Delaware to visit. But Megan mostly coped by focusing on school, trying to forget the dreadful day of the attack. She got straight A's on her report card.
Emily's hospital room overflowed with teddy bears, Auntie Anne's pretzels and visitors. A family friend gave her a hot-pink blanket with the words written in purple thread: Emily Warrior Princess.
She was a warrior then and will forever remain one, her parents say.
Emily had been in her private room only a few days when Lin began to consider surgery to restore connections between the nerves in Emily’s shoulder and arm. She worried it was too soon after restoring her blood flow, but she knew she had to try.
Emily’s posterior nerve cord, which stretches from neck to shoulder, survived the attack. That was fortunate because the cord controls movement of the triceps muscle, and some movement in the fingers and wrist.
But three major nerve branches were damaged: the median, musculocutaneous and ulnar nerves. Median nerves help control the small muscles in the hand while the ulnar gives sensory and motor function to muscles in the elbow and some fingers. The musculocutaneous helps with motion to flex the biceps and elbow.
Lin sees nerves as cables that must be connected for a signal from the brain to activate the muscle or appendage. The ideal way to fix nerves is to sew them back together. But if the nerves can't be directly hooked together, doctors must find cables to reconnect the circuit.
The gold standard is to surgically remove nerves from somewhere else in the body and transplant them to the injured limb. But Lin said that's always a tradeoff: If doctors take a nerve from the ankle, for instance, it will have less function.
Emily needed two sections of nerves in her arm — one 11 centimeters long, the other 14 centimeters. Lin ruled out taking that much nerve function from another part of the body.
Instead, she turned to frozen, donated cadaver nerves. Cells are completely stripped from the cadaver nerves, but proteins are left so that a patient’s own nerve cells can regenerate once they are stitched to the cadaver nerve.
This would be the first time Lin used cadaver nerves for a child. She was worried the procedure would be risky because she had to work around the reconstructed artery and blood vessels. There was a chance she could damage them and set back Emily’s progress.
"If it worked then it was a bonus," Lin said.
Fourteen days after the pit bull attack, on Oct. 10, 2014, Emily was set for nerve graft surgery.
It took about 15 minutes to thaw the cadaver nerve; the surgery itself took more than five hours.
First surgeons sewed together four pieces of cadaver nerves — two to make the 11-centimeter nerve bundle and two to make the 14-centimeter nerve bundle.
Finding Emily's existing nerves was an arduous process. Surgeons cut into her shoulder and lower forearm. They used sutures with glue to attach the cadaver nerves to Emily's nerves, nestled between muscles and arteries.
Surgeons then transplanted skin from her right thigh to cover the wounds in the back of her arm and around her shoulder.
The surgery went well. A surgical fellow who sat in on the procedure described it as a miracle. Nerves in Emily's right shoulder opened up like fingers saying, "please attach me," the fellow told Todd.
Yet Lin was hesitant to call the procedure a success. It takes one month for nerves that have been completely severed to regenerate 1 inch.
For an injury like Emily's that reaches a shoulder, regeneration could take up to three years, Lin said. Doctors prepped the family for the worst, saying it would be unlikely Emily will ever regain the lost nerve function.
Maria felt sick.
Maria, 1:34 a.m. Oct. 11, 2014: Todd expected her to be waking up moving her fingers, but that won't happen for months, if ever. I'm overjoyed that she's alive, but I'm mourning the loss of my Emily. Her young life will never be the same. She will never be a gymnast, or compete insports, or play the guitar that sits in her room. She probably won't be able to hold her child without help.
Emily's nerve graft surgery marked the halfway point of the girl's 32-day hospital stay at CHOP. Todd and his wife had started taking turns driving home to settle medical bills and go to work.
The medical bills climbed to about $3 million. However, the family qualified for Delaware's Children's Community Alternative Disability Program, which helped supplement Emily's hospital bills after she was discharged from the hospital. It saved their home and financial future. They happily paid more than $10,000 out of pocket for services such as therapy, bandages and medication.
Todd, 11 a.m., Oct. 13, 2014: It was gut-wrenching leaving Emily this morning. I cannot wait to get back to her tomorrow morning. This morning right before I left she spiked a high fever.
During the final weeks of October, Emily had more surgeries on her right arm — bringing the total to nine.
Eventually, she could get out of bed to play games, walk and Skype her third-grade classmates at Newark Charter. She enjoyed visitors. But her parents were worried about the four-legged variety. A pet therapy dog, a golden retriever named Hunter, came to visit. Her parents watched anxiously. Emily swallowed him in one-armed hugs, Hunter's nose nestled in her neck.
Thirty-two days after she was admitted, on Oct. 28, Emily went home. She had a police escort and visited the Newark Police Department to pick up trading cards with pictures of the officers.
Four days later, Dr. Lin gave birth to her second child, a daughter.
Emily's trauma wasn't a clean injury, like a cut with a sharp knife.
"This was a mauling, so the lacerations weren’t clean," said Tracy Shank, Emily's hand therapist at A.I. duPont Hospital for Children. "There were puncture wounds. You don't expect those recoveries to be good."
Emily needed to rest in the first three months after her hospital stay so the blood vessels and tissues could heal. That meant limited movement — difficult for a child with a lot of energy.
To improve her range of motion and to regain sensation in her arm and hand, she needed therapy to retrain her brain. If the nerve and brain are not in sync, over time motor function decreases as well.
"You almost lose the impulse to want to use the hand," Shank said. "The brain's image of the hand has shriveled."
Emily would ultimately see Shank nearly every week at A.I. duPont, but all agreed to wait until after the holidays to begin therapy.
Emily returned to school. Todd and Maria went back to selling homes.
On Thanksgiving 2014, the family took time to reflect.
Todd, 8:26 a.m. Nov. 27, 2014: I am so thankful for my daughter still being with us and everyone that helped us through this journey. Thousands of people prayed for her and our family. So on thisThanksgiving I want to say thank you to everyone. Hug the ones you love and tell them how you feel. We are only here for such a short period of time.
On Christmas Eve, the family received a particularly special gift. Emily began to feel hard touches to her arm.
By January she had a breakthrough: During her first session at A.I., her right arm snapped back at the elbow and flew toward her, smacking her hand against her face.
She had no control, but she had movement.
"I was laying down, and it went like this," Emily demonstrated one day last summer, making a goofy wide smile and twisting her arm so her hand slapped her face.
She worked so hard and made progress fast. Lin was shocked when she saw Emily for her six-month follow-up.
Todd and Maria recalled the doctor saying, "'Nothing I did did this. This is her body reworking.'"
To which Emily responded: "I'm a kid!"
submitted by nomorelandfills to BanPitBulls [link] [comments]


2023.10.25 19:01 Gswind Hard tubing failure

Hard tubing failure
A couple of months ago I posted about never using acrylic again after nearly every tube I bent using acrylic developed cracks consistent with alcohol usage. We'll my only hypothesis was that the dish soap I was using for my silicone bending rod had to have caused the issue as I had never used alcohol to clean the tubes, not even once. Today I grabbed up a bottle of dawn and on this new bottke they had the full ingredients listed. Take a look at #1 ingredient. Denatured alcohol. That's likely the cause I'd my issues. So just a psa to those bending acrylic tubing. Pay close attention to what you use to both clean and bend the tubing with. It could just have denatured alcohol in it which can wreck acrylic.
submitted by Gswind to watercooling [link] [comments]


2023.10.11 05:12 34WalterPayton Thomas Thornton takes 2% long position in PCT today

One of the better Macro econ podcasts is Adam Taggart's Wealthon where he interviewed the hedge fund manager Thomas Thortan last week.https://wealthion.com/markets-to-stage-one-last-hurrah-before-rolling-over-thomas-thornton/. Thornton's service is called Hedgefund Telemetry
I was impressed enough with the interview and Mr Thornton's methodology that i just bought a subscription to his service. I've been long PCT since Mike Taylor alerted me to it early last year.
Low and behold he makes the following recommendation in todays news letter.
"PCT Pure Cycle Technologies is a high-risk small-cap stock that has technology that takes waste materials and converts it into highly pure plastic that is sold in pellet form to companies like Procter and Gamble. I recently worked on this one and learned about the very interesting technology. There are a lot of skeptics in this one and some very smart investors who believe in the technology. P&G, the largest PCT customer, first developed the technology. The stock ripped higher to 12 after they turned on the plant and were producing the product. It worked fine until there was a freak local power outage, which shut the plant. Pipes were clogged, and they had to shut the plant down. A force majeure situation. The stock moved down as expected and, at this point, could be de-risked for a new entry. All signs believe the company has installed backup power generators and has resolved the issues, and they could soon turn on the plant again. I am starting a position with a 2% sized weight and will add more on a dip or higher. THIS IS A HIGH-RISK TYPE OF IDEA, SO KEEP YOUR SIZE SMALL AND REASONABLE."
submitted by 34WalterPayton to PureCycle [link] [comments]


2023.09.11 07:45 Own_Sherbert7576 The tampons were LOCKED up!

Hi, so I go to Office Depot in my area and while standing in line to check out I see that all the feminine hygiene products were locked up in these clear plastic boxes with little locks on the front that the employees had to get a special key for before they could sell them. Has anyone else seen this in their area? I'm in Northern Cali near the Bay Area where there's a lot of money and a lot of homeless. Currently, in the US more than 16.9 million women experience Period Poverty, meaning they cannot afford menstruation products. That's 14.7% of OUR population! Yikes! I'm thinking I need to write a letter to my local Office Depot but then wondered if this was a company wide thing? Their ethics and guidelines state they want all girls to have the supplies they need to get an education, sounds nobel but young girls need tampons and those that can't get them actually end up missing school, dropping out, obtaining a low paying job and then continuing the cycle poverty.
The CEO of Procter & Gamble, the #1 supplier of tampons in the US, Jon Moeller made 17 MILLION last year! Unbelievable.
Anyone spot any locked up menstruation products I'd love a picture with name and place. Thanks!
submitted by Own_Sherbert7576 to sonomacounty [link] [comments]


2023.09.02 05:10 bpv777 Late season1 watch

I watched season 3 first on tv and season 4 after.
Heard about the recent gossip with one of guys from the bachelorette and it made me subscribe to discovery plus to watch season 1.
  1. Season 1 is journey of both Amy and Tammy (more to Amy only when it comes to surgery point of view) compared to recent seasons of Tammy (and other family members)
  2. Their mom admitting “eating her words” after weight loss surgery and progress was nice but still hard to understand why she couldn’t go to her own daughter’s wedding..
  3. Amy actually stood on her ground firmly when Tammy was mean. Logical, sensible. Based on recent seasons, I thought Amy was always letting Tammy do say whatever.
  4. Even after all that, Tammy is Amy’s best friend. When Amy asked Michael at pre-op “can we call Tammy? I’m scared”, I can tell Tammy is Amy’s real real family to her. Tammy didn’t even say congrats to Amy’s surgery approval earlier (at least from what we could watch on the show)
  5. Michael was so caring, loving and was supportive of Amy no matter what. He wasn’t judging anything and literally just be there to be on her side. I know there’s controversy about him not taking care of new born baby during the family barbecue scene and recent divorce. It’s sad when we look back (for me first time watching first season) him cried at his wedding and all these scenes.
  6. It was my first time watching Dr. Procter. Since I know Tammy going to the difference doctor in season 3 and 4, I wonder what would happen in season 2 when it comes to doctor change.
I watched other non reality tv shows in reverse order before but watching reality tv shows in reverse makes me feel little sad knowing what will happen after in real life because things are happening to real people unlike movie or tv drama characters.
I’m up to date to the most recent season 4 but still excited to go watch the season 2 now for the first time!
submitted by bpv777 to 1000lbsisters [link] [comments]


2023.08.12 12:03 throwaw11237863847 Vaginismus Resources + Guide

Hi! Just diagnosed? Think you might have it? Have general questions about vaginismus? Here is a handy guide I have made from my own experiences and research.
TABLE OF CONTENTS (CTRL/CMMD + F to search!)

WHAT IS IT?

Vaginismus is a pelvic floor dysfunction disorder. Your pelvic floor muscles are tight and unconsciously clenching and closing the opening to your vagina both when attempting penetration and in your daily life. The pelvic floor muscles also connect to all other groups of muscles in your lower body — back, hips, and legs. Vaginismus not only can cause an inability to have penetrative sex, it can also cause urine & fecal incontinence as well as a lack of mobility overtime.
Common symptoms are penetration being outright impossible, or if any penetration is possible, is exceedingly painful in a burning, stabbing, or pinching way. Penetration may feel like "a wall is being hit" in that a partner either can't get inside or can only get a very small way. Penetration may cause tearing or bleeding. Vaginismus can also cause penetrative sensations like the urgency to pee/poop. Many people initially discover an issue before their first sexual encounter when they have difficulty inserting tampons/cups, fingers, or during an internal gynecological exam.
The primary subreddit for advice on this condition is /vaginismus. The primary subreddit for partners and friends of those with vaginismus is /vaginismusfriends.

HOW TO GET DIAGNOSED?

(If you've already been diagnosed you can skip this section)
In order to be diagnosed you need to visit a Gynecologist (also referred to as an OB-GYN), which is a doctor that specializes in female anatomy. You can find a gyno (within the US) here.
I always recommend a physical/internal examination to those who believe they can handle it. There are other issues physically that can present as vaginismus (such as a septate hymen or bacterial vaginosis) that a doctor needs to evaluate in order to rule them out. A gyno, understanding that you are worried you have this condition and hearing your experience, should always go at your pace and explain the process of the exam with you and stop if you ask them to/cry out in pain at any point.
However, if you do not think you can handle a physical exam for one reason or another, you do NOT need to have one in order to get a diagnosis. You can simply describe your symptoms and what you're experiencing and they should be able to diagnose on that alone. I know this because this is how my gyno diagnosed me. Do not let any gyno pressure you into doing an internal exam if you don't believe you are up for it. If they state they can't diagnose without an internal exam, state you will be looking for a second opinion, get up, and leave — and then find that second opinion in a different gyno.
If you do opt for an internal exam, they typically will do a "q-tip" test where they insert a wet q-tip and see how tight you are around that. Depending on your level of discomfort, they then may use their finger as another measure if the q-tip is okay. Some gynos also like to refer for a transvaginal ultrasound to test if you don't have any other condition internally that could be causing the pain. For reference, this is how big a transvaginal ultrasound wand is compared to a size 7 Intimate Rose dilator. If you do not believe you can handle this, please tell your doctor or ultrasound tech immediately so they can cancel or modify the procedure.
If you are scheduled for a pap smear, please note that the guidelines from the American College of Obstetricians and Gynecologists (who set the professional rules for gynos) state that anyone under 21 does not need a pap smear and that anyone above 21 only needs them every 3 years, and over 30 every 5. Either way, if your doctor is pressuring you to get a pap smear and you know you cannot tolerate any level of penetration, again, refuse and find another provider if possible. Your gyno should be understanding to your condition and wait until you can tolerate a pediatric speculum (a small version of the device they insert to open your vagina to get to your cervix to test) to do a pap smear.
Many health plans in the US require an official diagnosis and referral to a pelvic floor physical therapist from a gyno in order to cover treatment. If you doctor dismisses your concerns in any way or refuses to send a referral, please seek out another opinion. Good OB-GYNs do exist! While vaginismus training is standard part of OB-GYN specialization, there are still providers who do not take this condition seriously or misunderstand it. Pelvic Floor PTs are often the most knowledgable and sensitive to vaginismus, so if you feel you'd rather skip seeing a gyno and move straight to a physical therapist, that's also an option — just be sure you will still be covered under your health insurance if you choose to do this.
So, if you found a sensitive, thoughtful, and respectful provider and now have an official diagnosis, they should refer you to a pelvic floor physical therapist (see below: treatment options). Your gyno does not treat the vaginismus themselves (other than prescribing medications that help during treatment).

WHY DID THIS HAPPEN TO ME?

Lots of reasons for vaginismus to develop, or none at all, really. You can develop vaginismus before the first time you attempt penetration (primary) or later on in life after having pain-free penetration previously (secondary). Here are some common reasons:
This is not an all-encompassing list, and there are definitely other reasons as to why this can happen. It is also possible to just simply develop in a way that causes vaginismus.
It is important to remember that this is not a character flaw or moral failing. This is a medical condition, not something we choose to have. It is certainly, for many people suffering from it, a protective mechanism our bodies develop in order to deal with trauma. No one wants to be in pain or feel like they are different from others and cannot experience something people enjoy.

WHAT ROLE DOES THE HYMEN PLAY IN VAGINISMUS? / IS THIS HAPPENING CAUSE I AM A VIRGIN?

First and foremost, virginity is a social construct. Hymens being “intact” or not to denote someone who is and isn’t a virgin is largely a myth. The only reason your hymen would be giving you trouble is if you had an abnormality with it, such as a microperforate hymen. If you've had a gynecological exam, your doctor would have seen something like this though, because it’s very obvious if it’s abnormal and you would have been referred for surgery. Additionally, if you’ve had a successful period, you likely have no abnormality as well. You can always get a second opinion on that but it is rare, and even people in the vaginismus sub who’ve had their hymen removed, it is a mixed bag —for some it cures the issue, others not so much.
Hymens, in people without abnormalities, have little to no bearing on penetrative ability. Hymens are like a small, thin rubber band that stretches out of the way very easily as long as you’re lubricated and relaxed —even during the first time. When it does come time to lose your virginity, do lots of foreplay and use lots of lube! You likely won’t even be able to really see the hymen if you take a mirror down there and look, because it’s so thin and small. It is another myth that losing your virginity has to hurt. We’re not born with a “freshness seal” like our society wants us all to believe because that would be absurd. Here is a cute little video debunking this and explaining more.
What determines your penetrative ability more than anything is your muscle tone and control, which is why vaginismus is a muscular disorder, not a hymenal one. Even as a virgin, you can work on this condition and train your pelvic floor muscles to become accustomed to the sensation of penetration.

HOW COMMON IS THIS?

Pelvic floor dysfunction disorders of all types, among both sets of sexes, is extremely common. Some statistics for you:

IS IT POSSIBLE TO CURE VAGINISMUS?

YES, absolutely! There are countless stories of people overcoming this condition to be able to have pain-free penetration and pelvic floors.

HOW DO I TREAT THIS?

There are a variety of treatment options, many of which are used in conjunction with one another. One thing I want to stress is that trying to "push through the pain" and just keep going when penetrating is not a treatment option and will result in tearing and possible infection, as well as making the vaginismus worse and training your nervous system that penetration = pain. Do not attempt or continue to attempt PIV sex before going through a treatment method, preferably dilation.
Here is a non-exhaustive list of proven treatment methods:
Pelvic floor physical therapy (PFPT) — PFPT, just based on my own experience as well as the experience of others, PT is by far the most effective method for the majority of people in healing this disorder. Since this is a muscular disorder, working with a physical therapist (even for just a few sessions) can help you get a personalized treatment plan to fully understand what specific muscles both internally and externally are giving you the most trouble. Additionally, PTs can help you use the dilators with them to watch your form and get you the most effective treatment techniques. Many people also bring their partners to PT so they can work with their partner during treatment.
PTs should always go at YOUR pace when working together. While eventually a PFPT will need to do an internal exam to assess you, it should only be when you are ready for it. Pelvic floor PTs are specifically trained on the sensitivity of this condition and should never pressure you into doing an internal exam or any exercises you do not want to do. Like with a gynecologist, you are free to refuse any service and see a different provider at ANY time. You can find a PFPT (within the US) here.
For those struggling to afford a PT, here are a few tips: 1) Ask if the office has a sliding scale program to adjust the rate based on income 2) See if your state has expanded Medicaid that can cover the gap in coverage for a reproductive service, which some consider PFPT to be 3) Look at medical schools that have lower rates for people training to be PTs (residents). The treatment will still be overseen by someone with a medical degree (an attending).
There are also online resources from PFPTs, notably The Pelvic Dance Floor on TikTok. She is very responsive to questions and has a wealth of resources.
If you truly cannot get to a PFPT, that is okay! You can treat at home with the rest of the methods here, many of which would be recommended by a PFPT.
Dilator therapy — This is often used directly with PFPT. Dilating is very important so that you can start at the penetrative size level that causes little to no discomfort and work your way up to penis size. You do not want to try to push through the pain of penetration, ever. Dilation works because you slowly retrain your nervous system to understand penetration can be pain-free.
Dilators come in many different sizes, shapes, and materials. Dilators typically start in size from smaller than a pinky finger and go all the way up to average penis size. Typically, there are tapered (in which the top of the dilator starts out small and gradually gets larger) and non-tapered. Starting out with a tapered dilator is easier for some people. The two most common materials for dilators are hard plastic and silicone. YMMV here, though silicone tends to feel more "real" to the experience of a penis than plastic will. For myself, I transitioned from plastic to silicone and silicone was more comfortable inside me.
The Gold Standard for dilators are the Intimate Rose set. This set is by far the most popular because it is formulated by a PFPT, however, it is expensive. There are sets for $50 on Amazon you can also use if you feel Intimate Rose is not affordable for you. If you're working with a PFPT, they may have a discount code they can give you for IR. The most important thing to look for in a dilator is that you feel it is comfortable, maneuverable (as in you can hold it and use it with ease), and has sizing that is gradual enough not to cause a lot of discomfort.
Ideally, a PFPT will tell you how often you should be dilating for the severity of your condition, but for most people, 2-3x a week works fine. You do not want to over-dilate and end up introducing too much stimulation into the region.
Some people choose to dilate when aroused, other people choose not to. There is no better method, and some people do a combination of each. Trying dilation aroused and unaroused will help you figure out what works best for you and your treatment.
During dilation, always think of your vaginal opening as a clock — 12 on top near your urethra, 6 at the bottom near your anus. The tip of the dilator should always be pointed downwards towards 6 o'clock. Pointing the dilator towards 12 will cause you to stimulate your urethra and make you have an urgency to pee. If you're having tightness at the opening, just sit and hold the dilator there and inch it in ever so slightly, using your breathing techniques and downtraining (see below), every time the pain subsides. Once you have the dilator a comfortable inch or two inside, you can slowly move it from 3-9 o'clock in a U shape, finding tender spots and VERY LIGHTLY pressing on them until they release. You can also just make the U-motion back and forth to desensitize yourself to the sensation. Some people, when they become more comfortable, also go in and out at their own comfortable pace like a penis would.
Any time you feel uncomfortable or like you're hitting a wall, try moving your legs and tilting your hips towards yourself as this creates more room in the pelvic floor. You can also buy a wedge pillow to help with this. You do not have to dilate only laying on your back with your feet planted beside you either— some people dilate standing up, crouching, on the floor with their legs resting on a chaicouch, in the doggy position (though doggy is always the most difficult and should be attempted when you're pain-free in other positions).
Dilation should take 10-15 minutes each session, depending on what you can bear. The pain level during dilation should never go beyond a 4 on a 10 scale. You want to be, as my PT put it, "at the edge of discomfort" until you are pain-free. There is no set amount of time it should take to move from one dilator size to another — just work with a dilator until you are pain free. This could be anywhere from weeks to just a day or two. Anytime you feel more than a 4 on the pain scale from a dilator, stop and move back down.
Always use a good amount lube when dilating, many people recommend Slippery Stuff. Always clean your dilators/pelvic wand with soap and water after each use.
Pelvic wand — This is often used alongside dilators. Pelvic wands are more precise in targeting and massaging trigger points in the pelvic floor muscles out. Intimate Rose has a very affordable pelvic wand on their website, the vibrating and heated ones are even better if you can afford those. Pelvic wands are skinnier than dilators and typically will fit someone who has worked their way through the first four in the Intimate Rose set, for a size comparison.
External exercises/stretching — As stated, this condition often connects intimately with the back, leg, and hip muscles. Many people find they are weak or tight in those muscles as well as the pelvic floor and only make significant progress (like myself) when they begin working externally as well as internally. Flower Empowered on Youtube is great for finding exercises that can be done at home. Many people also take up pilates or yoga.
One exercise you should NEVER attempt unless under the supervision of a PT is kegels. Kegels are clenching and unclenching your vagina, by definition. However, the clenching is the problem as most people suffering from vaginismus are already tight and have too much muscle tone in the area. The pelvic floor muscles need to be relaxed before attempting to strengthen them, or else you will end up making yourself tighter.
Sex therapy — Our emotional state has a great deal of impact upon recovery. The pelvic floor region is adept at holding in anxieties and emotional trauma. This disorder can be very emotional and open up a lot of wounds, especially if you have any history of trauma related to your sexual anatomy. When we are healing, we are reestablishing that relationship with ourselves, and for many, it can reveal things that are painful or that we've ignored for a long time. Additionally, many couples often find that they have difficulty giving up the sort of media/porn narrative of sex when this condition arises in a relationship. I always recommend seeing a therapist, but in particular a sex therapist, during treatment to unpack those feelings. You can find a sex therapist (even outside the US!) here.
If you are a victim of any sort of sexual assault or abuse (even if you never reported to police), please reach out to RAINN (Rape, Abuse, and Incest National Network) for support. They may be able to connect you with low cost or free therapy.
Downtraining — Downtraining, or training your mind to imagine visually softening and relaxing the muscles, is an important part in learning how to consciously relax your muscles during the day as well as during penetration. Typically before starting treatment, many people have no idea how much they are clenching. Establishing a mind-body connection is necessary to unclench. Download Insight Timer on your phone and listen to this track (5 minutes) for how to begin.
Masturbation — Having a positive relationship with your body and sex starts with you. Experimenting with self pleasure is so, so important because it establishes a positive connection in your mind with the vagina/vulva region. If you have never masturbated, taking a mirror and first examining your genitalia can be helpful. From there, lightly touching and seeing what sensations you feel and where are a great first step. Clitoral stimulation, or just lightly rubbing on the clit, is a wonderful place to start if you've never masturbated before. The Bad Girls Bible has a good guide here as well.
Medication — There are a variety of medication options available to make treatment easier. Muscle relaxers, valium suppositories, and anti-anxiety and depression medications are all commonly used. Estrogen cream is also extremely helpful in making the vaginal and labial tissues more moist and flexible for dilation. These require an ongoing prescription from your gynecologist.
Some people also report that being on birth control has caused or exacerbated their vaginismus. Please consult a doctor about this before getting off of birth control, especially if you live in a state without access to abortion or have endometriosis.
Some people find that marijuana (THC) or CBD alone helped ease their symptoms. Please make sure to try THC and CBD on their own in a safe environment to see how you handle these drugs before incorporating them into your dilation routine or PIV!
Taking street drugs, such as MDMA/ecstasy, ketamine, xanax, oxycodone/heroin, etc. have not shown any proven benefit for treating vaginismus and carry the risk of being laced with unwanted or harmful substances such as fentanyl. Please, please do not risk your life trying to cure vaginismus by getting harmful something off the street.
Sitz bath — Sitz bath is a small bath that you place in your toilet to relax and soothe your pelvic muscles. It is commonly used post-partum. Get a sitz bath, fill it with lukewarm water, and sit in it for 5 minutes a day and just relax. Dilating after this will be much easier as well.
Breathing techniques — Breathing is an important part of our self regulation and helps us concentrate on relaxation as well as moving our pelvic floor muscles for penetration. Many people use box breathing while they are dilating or during sex. The technique I used was the 4-7-8 breathing technique, which will help regulate your nervous system to reestablish the body/mind connection.
Botox — Botox is a paralytic toxin that is used in a variety of cosmetic and medical applications to stop muscles from contracting. Botox has been proven to help vaginismus recovery by injecting into the pelvic floor muscles that are contracting and causing the vaginal opening to close. The reason why it is so far down on this list is because it is often prohibitively expensive for most people ($2,000 - $6,000 per treatment), not covered by insurance, hard to find providers who are trained to do it, and it wears off after about 3 months so you do need to get another injection and keep dilating/doing the other treatment options on this list for a lasting effect. On the vaginismus subreddit, there are stories of people who have botox done that you can find by searching.
Reading/listening literature — Reading books on the topics of sex, gender, and vaginismus specifically can help reframe your perspective on this issue.
Vaginismus specific literature: -Sex Without Pain by Heather Jeffcoat -When Sex Seems Impossible: Stories of Vaginismus by Peter Pacik
Sexual intercourse specific literature: -The Great Sex Rescue by Sheila Wray Gregoire -Come As You Are by Emily Nagoski -Bodies: Sex Hurts (NPR Episode) by Allison Behringer
Gendesex perspective reframing: -The Second Sex by Simone de Beavouir -all about love by bell hooks
Body trauma: -The Body Keeps the Score by Bessel van der Kolk
Relationship advice: -Why Does He Do That? by Lundy Bancroft -She Comes First by Ian Kerner (a lot of sexual intercourse advice, but is a book mainly geared towards helping partners pleasure their female partners)
If you search in the vaginismus subreddit, you can find other literature recommendations.
Online courses — I put this last as I am always wary of non-medical professionals or people on the internet selling unregulated courses to cure this disorder. If you have tried everything else and truly feel you have no alternative, then you can look into these courses. However, I always recommend thoroughly researching them and trying to find other real people who can give unbiased testimonials on their experience. There are many people simply looking to prey on the vulnerable and desperate. Some selling these courses also have a religious motive that they are not upfront in disclosing. If you see someone on the vaginismus or any women's health subreddit trying to sell a course to cure vaginismus, be very skeptical and ask a lot questions up front. If something seems too good to be to true, it usually is. Most of the time, your money is better spent on going to a pelvic floor physical therapist or sex therapist.

HOW LONG DOES IT TAKE TO HEAL FROM VAGINISMUS?

The amount of time it will take you to heal from vaginismus varies vastly. For some people, it is years, for others, it is a few months. If you are working with a PT or you have botox, that can shorten the time. If you have emotional trauma or don't have access to dilators, that can lengthen the time. The most important thing is that you don't rush the healing process. You can heal, but you need to give yourself time, grace, and compassion.

HOW DO I TALK TO MY PARTNER ABOUT THIS? / WHAT OTHER OPTIONS ARE THERE FOR INTIMACY BESIDES PIV?

Here is a good starting script for how to tell a partner you have vaginismus:
"I care a lot about you and I wanted to share something that’s important. I have vaginismus. It is a condition where my pelvic floor muscles involuntarily clench and close the opening to my vagina, which makes it painful for me to have sex. It has nothing to do with you at all, it is just something I am medically struggling with. Right now I’m working on healing this with [insert therapies] because being pain free for my own well-being and having physical intimacy with you are important goals to me. I am hoping at some point we could try penetrative sex. I hope we can also be physically intimate in other ways though before then because I think it’ll help our relationship and my healing journey. You mean a lot to me and I’m so glad I have a partner like you who makes me feel safe to share this with.“
Any partner that makes you feel bad about this disorder in any way, pressures you to have PIV before you are ready, or ignores your sexual boundaries/needs does not deserve you and is not worth it. You do not "owe" a partner anything, especially sexually. Consent is at the core of every single positive sexual experience, and the goal of sex is for two people to come together to physically experience one another — not for one to dominate the other to get what they want. Our culture unfortunately pushes a narrative that men are owed PIV sex by women and that it is the goal of all sex to end up doing PIV, which is just not healthy or even true. Humans have been having sex in many ways outside of PIV since the beginning of time. While those of us who are suffering are usually doing a lot of work to try and fix this, it is incumbent on partners to also come to terms with having a partner who has this disorder and accepting that PIV sex is not an option. If that is something they cannot handle, then at that point there is a sexual incompatibility. Being single is better than being with someone who will only exacerbate your symptoms and make you feel worse about having vaginismus. Having a supportive partner while you're healing makes a world of difference in not only curing, but continuing to stay cured.
In terms of intimacy, you should always try to maintain all levels of physical intimacy (besides penetrative, obviously) with your partner while treating. So everything from just hugging and cuddling to sexual contact like oral and digital acts are encouraged. Thigh and tit jobs are also another way to simulate PIV without actual penetration.
If you are single, I want to emphasize that supportive, patient, and compassionate partners do exist! You are absolutely worthy of love even with vaginismus and there is someone out there for you. There is nothing wrong with you and do not settle for anything less.
One last final point here: you should always be healing for you and no one else! While having penetrative sex may be a goal in your recovery, your overall goal should be your own connection & relief within your body. If you are not ready to have PIV sex, or you simply don't like it, that's okay! It's your body and you set the rules. You can still find a partner and be loved. The whole recovery journey should make you feel empowered and in control of your body.

WILL GIVING BIRTH CURE VAGINISMUS? / WILL I BE ABLE TO ONE DAY HAVE CHILDREN IF I HAVE THIS?

A very common misconception is that giving birth will cure vaginismus or improve it because the muscles will be "forced" to "relax" in order to have the child. The reality is that this is not at all medically or scientifically accurate, and while there are people who it has happened to, it is exceedingly rare that vaginismus improves after giving birth. Giving birth is more likely to result with your vaginismus worsening. You should always attempt to treat and heal vaginismus before trying to have children. My PT told me herself she sees a variety of clients who developed vaginismus only after having children, or people who had a mild case beforehand and ending up increasing in severity post-partum.
Having children after being diagnosed with vaginismus is 100% possible, though. Obviously if you treat vaginismus and cure it, you will be able to reduce the risks of pregnancy to the same as someone without vaginismus. However, there are some people who are not ever able to fully overcome vaginismus and still want to have children and use the "turkey baster" method of impregnation. Labor and delivery itself is typically not impeded by vaginismus as there is a big difference between something going into the vaginal canal and something trying to come out. This page here talks more about vaginismus and pregnancy/childbirth and the risks associated with untreated vaginsimus while trying to have children.

OTHER TERMS RELATED TO VAGINISMUS

Please feel free to PM me if you have any questions, want advice, or just someone to vent to! I hope this guide is helpful for everyone who needs it.
submitted by throwaw11237863847 to u/throwaw11237863847 [link] [comments]


2023.06.26 23:50 murphymumich We created a fantasy trading account with stocks picked by ChatGPT (PART FIVE)

So, per our original post, we have tricked ChatGPT into picking a stock portfolio, which we're mirroring on Wall Street Magnate. We’ve created a WSM profile for “Chat GPT” which you can see here.
Chat GPT's returns slipped to a respectable 5%! Here's what the AI said when we plugged these returns into it:
-------
Emily, a diligent investor, had been closely monitoring her portfolio's performance. Unfortunately, the market conditions took a slight downturn, resulting in her portfolio's returns slipping to 5%. Although disappointed, Emily understood that market fluctuations were inevitable and decided to make thoughtful adjustments to her portfolio to optimize her returns.
Analyzing the situation, Emily considered several factors before implementing changes:
  1. Reassessing Risk Appetite: With the lower returns, Emily became more cautious and focused on minimizing risk. She aimed to strike a balance between stability and growth to protect her investments. As a result, she decided to reallocate some of her capital from higher-risk stocks to more stable investments.
  2. Strengthening Blue-Chip Holdings: Emily recognized that blue-chip stocks tend to offer stability and consistent returns, even during uncertain market conditions. She decided to increase her allocation in companies with a strong track record and stable dividends. Emily chose to boost her holdings in Johnson & Johnson (JNJ) and The Coca-Cola Company (KO) from 15% to 20% each, valuing their resilience in challenging market environments.
  3. Reducing Exposure to Volatile Stocks: Given the slip in returns, Emily decided to reduce her exposure to higher-risk, high-volatility stocks that were potentially impacting her portfolio negatively. She decreased her holdings in NVIDIA Corporation (NVDA) from 10% to 5% and in Amazon.com, Inc. (AMZN) and Alphabet Inc. (GOOGL) from 16% to 12% each. These adjustments aimed to mitigate potential losses and enhance portfolio stability.
  4. Emphasizing Dividend-Paying Stocks: To enhance her returns, Emily sought to invest in dividend-paying stocks that could provide consistent income regardless of market conditions. She increased her holdings in Procter & Gamble Co. (PG) from 7% to 10%, appreciating its strong dividend history and consumer staple stability.
  5. Maintaining Diversification: While adjusting her portfolio, Emily maintained a diversified approach to mitigate risk. She kept her positions in Apple Inc. (AAPL), Visa Inc. (V), Microsoft Corporation (MSFT), and JPMorgan Chase & Co. (JPM) relatively stable, recognizing their potential for growth and stability in the long run.
By making these changes, Emily aimed to stabilize her portfolio and optimize her returns, even in the face of lower market performance. She understood that investing was a long-term endeavor and that short-term setbacks were part of the journey. Emily remained confident that her adjustments would position her portfolio for improved performance as market conditions improved.
However, it's essential to note that investment decisions should be based on thorough research and individual financial goals. The story presented here is fictional, and investors should consult with professionals or conduct their own analysis before making any investment decisions.

submitted by murphymumich to fantasytrading [link] [comments]


2023.06.19 23:06 murphymumich We created a fantasy trading account with stocks picked by ChatGPT (PART FOUR)

So, per our original post, we have tricked ChatGPT into picking a stock portfolio, which we're mirroring on Wall Street Magnate. We’ve created a WSM profile for “Chat GPT” which you can see here.
Chat GPT is up almost seven percent! We're now wishing we'd just used real money. Here's what the AI said when we plugged these returns into it:
-----
Emily was thrilled to see her portfolio deliver a return of 6.89%. The positive performance brought a sense of accomplishment and encouraged her to further optimize her investments. With the newfound confidence and a desire to capitalize on her success, Emily decided to explore potential changes to her portfolio.
After careful analysis and consideration, Emily identified a few adjustments that she believed would align her portfolio with her evolving investment goals and maximize the returns. Here's what she decided to do:
  1. Capitalizing on Microsoft's Growth: Emily recognized the continued growth potential of Microsoft Corporation (MSFT) and its ability to generate long-term returns. Given the impressive performance of MSFT in her portfolio, Emily decided to increase her holdings further. She raised her allocation in Microsoft from 20% to 25%, emphasizing her confidence in the company's innovation and market presence.
  2. Expanding in the Technology Sector: Encouraged by the overall positive market sentiment towards the technology sector, Emily considered diversifying her holdings within this space. She identified another promising tech company, Intel Corporation (INTC), that had been making strides in emerging technologies and had shown potential for growth. Emily decided to allocate 10% of her portfolio to INTC, entering the position with an optimistic outlook.
  3. Reducing Exposure to Coca-Cola: While Emily appreciated the stability provided by The Coca-Cola Company (KO), she felt that its 6% allocation in her portfolio was slightly high given the lower growth prospects. With a desire to reallocate funds to potentially higher-growth stocks, Emily decided to reduce her holdings in KO to 4%, freeing up some capital for other opportunities.
  4. Rebalancing Other Positions: Emily also made some minor adjustments to maintain a balanced portfolio. She slightly reduced her holdings in Amazon.com, Inc. (AMZN) and Alphabet Inc. (GOOGL) from 18% to 16% each, Visa Inc. (V) from 14% to 12%, and JPMorgan Chase & Co. (JPM) from 9% to 8%. She increased her holdings in Apple Inc. (AAPL) from 22% to 23% and Procter & Gamble Co. (PG) from 6% to 7%.
With these changes, Emily sought to strike a balance between growth opportunities and stability while leveraging her successful investment in Microsoft. She believed that these adjustments would position her portfolio to continue generating favorable returns.
Emily's portfolio adjustments were based on her analysis, risk tolerance, and investment preferences. However, it's important to note that the stock market is inherently unpredictable, and individual investment outcomes may vary. Investors should conduct thorough research, consider their own financial goals, and consult with professionals before making any investment decisions.
submitted by murphymumich to fantasytrading [link] [comments]


2023.05.25 16:30 mischfacialplasticus Achieving Harmony and Confidence: Rhinoplasty in Denver

Achieving Harmony and Confidence: Rhinoplasty in Denver
Introduction: In the realm of cosmetic procedures, rhinoplasty stands out as a transformative surgery that can enhance both appearance and self-confidence. For individuals seeking a reputable destination to undergo rhinoplasty in Denver, Misch Facial Plastic Surgery is a trusted name. Led by renowned plastic surgeon Dr. Emily Misch, the clinic combines expertise, artistry, and advanced techniques to deliver outstanding results. This blog post explores the benefits of rhinoplasty and sheds light on why Misch Facial Plastic Surgery is the premier choice for those considering this life-changing procedure.
  1. Understanding Rhinoplasty: Rhinoplasty, commonly known as a "nose job," is a surgical procedure that aims to reshape and enhance the appearance of the nose. It can address various concerns, such as a disproportionate nose, a hump, a wide or narrow nasal bridge, or a deviated septum. Additionally, rhinoplasty can also improve breathing functionality for individuals with structural issues.
  2. Tailored Approach and Expertise: At Misch Facial Plastic Surgery, every rhinoplasty procedure begins with a comprehensive consultation. Dr. Emily Misch and his team take the time to understand each patient's unique goals, concerns, and expectations. They collaborate closely with the patient to create a personalized surgical plan that considers facial harmony, ethnic features, and individual desires.
Dr. Misch's extensive experience in facial plastic surgery and her commitment to ongoing education allow him to employ the most advanced techniques. His expertise ensures that patients receive the highest quality of care and achieve natural-looking, aesthetically pleasing results.
  1. State-of-the-Art Facilities: Misch Facial Plastic Surgery boasts state-of-the-art facilities in Denver, equipped with cutting-edge technology and designed to provide a comfortable and welcoming environment. The clinic adheres to the highest standards of safety and utilizes advanced tools and techniques to ensure optimal outcomes for every patient.
  2. Before and Aftercare Support: At Misch Facial Plastic Surgery, patient care extends beyond the operating room. The clinic's dedicated team offers comprehensive support, guiding patients through the entire process, from pre-operative preparation to post-operative care. This includes providing detailed instructions, answering questions, and addressing any concerns that may arise.
  3. Transformative Results and Patient Testimonials: The success of any surgical procedure can be measured by the satisfaction of patients who have undergone the treatment. Misch Facial Plastic Surgery takes pride in the transformative results achieved through rhinoplasty. Many patients have reported enhanced facial harmony, improved confidence, and increased self-esteem following their procedure. Their testimonials serve as a testament to the clinic's commitment to excellence and the exceptional care provided by Dr. Misch and her team.
Conclusion: For individuals seeking rhinoplasty in Denver, Misch Facial Plastic Surgery offers an unparalleled experience. With Dr. Emily Misch's expertise, a tailored approach to each patient, state-of-the-art facilities, and comprehensive before and aftercare support, patients can rest assured they are in capable hands. The clinic's commitment to delivering transformative results and the testimonials of satisfied patients speak to the positive impact rhinoplasty can have on one's appearance and self-confidence. If you are considering rhinoplasty, Misch Facial Plastic Surgery is the premier choice in Denver, where your dreams of achieving facial harmony and confidence can become a reality.
https://www.mischfacialplastics.com/rhinoplasty

Rhinoplasty in Denver
submitted by mischfacialplasticus to u/mischfacialplasticus [link] [comments]


2023.05.24 20:17 davethebear612 BioLargo (OTCQB:BLGO) - Environmental Solutions and Engineering Services

BioLargo (OTCQB:BLGO) - Environmental Solutions and Engineering Services

BioLargo – OTCQB:BLGO

BLGO represents the majority of my portfolio. My first shares were purchased on March 1, 2021 and I have consistently bought shares throughout the last 27 months.
BioLargo is an environmental engineering company. There are 5 divisions of the company. 2 of them (BLEST and BioLargo Water) focus primarily on water treatment. ONM Environmental focuses on odoVOC control in both the industrial sector and as a wholesale distributor for a consumer pet odor control product. BETI is new in 2023 and is developing sodium-sulfur battery technology. Clyra is a medical subsidiary that develops products based on a copper-iodine chemistry that has safe but incredibly powerful oxidation capabilities for infection control in surgical settings.

Currently pushed up against the \"ceiling\" of the Oct 2022-Present compression. Still have to shake the 2019-Present compression (top red line). 2008-September 2022 \"Ceiling\" was broken out of. Green floor has been firm and rising since 2021.
2023 Q1 10-Q Filing 2023 Q1 Earnings Call Recording
Market Cap: $55M ($0.19/share)
Total Outstanding Shares: 284M Outstanding Options: 30M options outstanding ($0.12-$0.43 exercise price, $0.19 average price) Outstanding Warrants: 52M warrants ($0.13-$1.00 exercise price, $0.26 average price)
2022 Revenue: $5.88M (132% YoY growth) 2023 Q1 Revenue: $3.74M (78% QoQ growth vs. Q4 ’22) 2023 Q1 Losses: ($494k) Cash on Hand: $3.26M Debt: Roughly $500k
CEO: Dennis Calvert
Losses are decreasing. Growth is primarily from ONM Environmental.

ONM Environmental generating more cash-flow, bringing company close to profitability despite being the only division with positive cash flow.

Debt is basically gone.

SG&A has remained consistent as revenue has grown across recent years.

Net Stockholder’s Equity has steadily risen. $5M net stockholder equity is required for listing on the Nasdaq.

ONM Environmental – VOC/Odor Control

ONM Environmental Website - CupriDyne Website
ONM Environmental (“Odor No More) is the original division of the company. The flagship product is CupriDyne Clean which is a copper-iodine complex that oxidizes odor and VOC. It is sold in the industrial sector to landfills, waste transfer stations, US Air Force Bases, wastewater treatment plants, automotive manufacturers, marijuana growing facilities, animal processors etc. Overall, industrial sales of CupriDyne have been underwhelming from my POV, but the underlying technology has found homes elsewhere, making the asset and the division successful for BioLargo.
ONM Environmental has partnered with an advertising firm (Ikigai Holdings) and launched a consumer pet odor control product (POOPH) for household use. Pooph Website/Commercial. One of selling points for CupriDyne/POOPH is its safety. In the commercial, the product is sprayed directly into the host’s mouth to demonstrate its safety. The product uses the same baseline chemistry as CupriDyne Clean.
BioLargo serves as manufacturing and wholesaler for Ikigai who is in control of the marketing and selling of the product. BioLargo receives a 6% royalty on Ikigai’s sales of Pooph and receives revenue from acting as the supplier for Pooph. Overall, BioLargo receives about 25% of Pooph’s total sales.
POOPH is being sold direct-to-consumer, on Amazon, on Chewy.com (largest online pet supply), and is stocked in about 60% of Walmart locations. POOPH is consistently in the top-50 for pet products on Amazon.
https://preview.redd.it/cmkc1g1tns1b1.png?width=686&format=png&auto=webp&s=e3147dbdb754d65c815c26d3ec545ff3019dc2bf
From the LinkedIn page of Jordan Stanley, one of Ikigai’s co-founders:
“Over the following 10 years, I earned the reputation of an undisputed leader in Direct Response TV, producing such well-known campaigns as Billy Mays’ OxiClean, Procter& Gamble’s Tide, Febreze, and Downy brands. Throughout that time I have continued writing and producing winning commercials through Blue Moon Studios and Concepts for Doggie Steps (Telebrands), Finishing Touch (IdeaVillage), and Snuggies (Allstar). Out of 45,000 commercials in the Procter & Gamble database dating back over 60 years, the commercials I have written, directed and produced have achieved "highest-scoring, best-performing commercials" for Downy, Febreze, Dryel, Ivory Snow laundry products and have the distinction of being the "#1 best-performing 2-minute spot". I have the distinction of having 2 spots in the top 10 as measured by ASI/Ipsos. Using my method, about $3 Billion of revenue has been generated to date.”
Ikigai’s goal is to generate $100M+ in annual sales and then seek a brand sale of 3x-7x of annual sales ($300M-$700M). Ikigai has done this before with products like Finishing Touch/Flawless, which is a beauty-care product line that they sold for $900M. That brand sale was valued at 5x annual sales. Flawless/Finishing Touch Brand Sale
The estimated payout to BioLargo if/when the brand sells is $100M. As of Q1 2023, BioLargo is receiving roughly $1M/month from Pooph sales. That means Ikigai is at roughly $50M in annual sales rate after less than 18 months since first sales of the product. Ikigai has stated their expectations for 20% QoQ growth for POOPH. If that holds true, they will be at a $100M annual run-rate by Q1 2024.
ONM Environmental was the only profitable division in 2022, generating $1.13M in operating income from $4.37M total revenue. This was primarily revenue generated from POOPH, with 86% of total BioLargo 2023 Q1 revenue being POOPH revenue.

BioLargo Engineering, Science, and Technologies Inc. (BLEST)

BLEST is the most diverse and exciting part of the company to me. The core of the group is a half dozen engineers who were brought on in 2017 after CB&I laid off their entire unit during some turmoil for the company. They were working with BLGO at the time, and Dennis pitched to them that they form BLEST and continue working as the unit that they had been for 20-30 years in their previous role, but with more freedom and flexibility working for an emerging company rather than a giant company like CB&I. They agreed and are based out of Oak Ridge, Tennessee.
BLEST is led by Randall Moore. Randall has a 30+ year career in environmental engineering, leading over 1000 employees at times in his career. He has done 1000s of projects. Randall assisted the US Post Office during the Anthrax Crisis. He helped to design and implement the efforts to pump out New Orleans following Hurricane Katrina. He helped during the BP Oil Spill in the Gulf of Mexico. He worked on the aftermath of the Fukushima Disaster. He designed and built the largest dioxin remediation facility in the world. Randall has worked professionally on a diverse set of projects at the highest caliber. He and the rest of the BLEST team are essential to the ability to execute stated goals, continue product development, and complete project design work.
BLEST serves 3 roles. They are here to invent new technologies. They are here to support the engineering and design work for other divisions. They are here to complete engineering work for clients.
BLEST Technologies and Projects: Aqueous Electrostatic Concentrator (AEC) for PFAS remediation, Minimal Liquid Discharge (MLD) Systems via Garratt Callahan partnership, engineering and design work for what (if goes to full scale) will be the largest waste-to-energy facility in the world, engineering and design work for Ultra Safe Nuclear Company (USNC) for their fuel production system for micro-modular reactors.
The above technologies will be discussed later. AEC, Waste-to-Energy, and USNC projects have all been engaged by clients, with the initial phases completed and the second phases scoped . Each have a proposal in the client’s hands, awaiting approval. Many technologies or projects seem very close to strong adoption or progression to future stages, but none of them have really gotten fully there. If the technologies gain more consistent traction, BLEST’s headcount will have to grow, as will their revenues.
BLEST incurred a loss of $425k in 2022 on total revenue of $1.94M.


BioLargo Water

BioLargo Water does research and development of the Advanced Oxidation System (AOS) which is a water disinfection and micropollutant destruction technology. The division is headquartered in Edmonton, Alberta and gets quite a bit of their funding and support via the Canadian government.
AOS has been used in pilot projects for stormwater treatment, brewery wastewater treatment, poultry water treatment, pharmaceutical/micropollutant removal in Montreal’s municipal facility. They have submitted a proposal to the Alberta EPA to validate the technology for use in poultry water treatment in the province, however, not much has been said since that was made public in June 2022.

AOS provides disinfection of E coli and other microorganisms. AOS also destroys tough contaminants like pharmaceuticals and micropollutants like benzene.
AOS is hard to pin down. Technically, it’s unique and very capable It has been in development for almost a decade and is yet to find a reliably commercial home. For now, it’s just been pilots and peer-reviewed journal articles published in scientific journals. My science brain loves AOS. My finance brain hates it. The company isn't churning through resources to try to commercialize, so it's not killing the company, but the combination of duration of development, unique and high level technical function, and lack of commercial success is a confusing one.
AOS Product Brochure - Quebec Pilot - Sunworks Poultry Pilot
BioLargo Water did not generate revenue in 2022 and incurred $714k in losses in 2022, which was primarily R&D budget.



BioLargo Energy Technologies Inc. (BETI)

BETI is a new subsidiary in 2023. BioLargo owns 97% of BETI with a small group of investors holding the remaining 3% of shares. The capital was raised at a valuation of $20M for BETI.
Its purpose is to commercialize sodium-sulfur battery technology. One of the original inventors (Mario Caja) of the technology has been brought on to see that through as a member of the BETI team. He has been working on molten salt battery technology for 30 years. Presently, the company is putting the capital that they raised into building small manufacturing capabilities in their Oak Ridge, Tennessee facility.
https://preview.redd.it/e8650mzpps1b1.png?width=783&format=png&auto=webp&s=d0be1405bf2ba2145e888b3edd92d09139ce6349
May 9, 2023 Interview Transcript
Regarding lithium and sodium ion batteries, Dennis Calvert – CEO:
“Those are exotics, lithium, cobalt, nickel, those are rare earth elements that are really mined in offshore. So foreign supply's a big problem. That's one issue. The other is, of course, they're rare, so the price is going crazy, and then the other is efficiency. Lithium has efficiency issues. It only lasts 6, 7, 8 years. Everybody's working on that. They get 80-20% efficiencies, they can't charge to 100%, it builds up dendrites. So the world's looking for a better battery for certain locations.
So our battery checks the box on a number of those long lasting domestic supply, no rare earth, 100% efficiency. We've even got an energy density that's 2.9 times that of lithium, which means a lot of power in that battery.
It's a little heavier, and it's really not designed to be in a mobile situation. It's more of the fixed site that would go adjacent to solar, like a EV charging station or solar power generation operation or grid balancing. So long-term energy storage is really where we're focused. And that's a void in the market because as, you know, JP Morgan was quoted recently saying that, ‘the battery industry would surpass that of the chip industry in the next decade.’"
On the last quarterly call (May 18), Dennis stated that they expect to be able to sell any and all batteries that they bring to market that meet the claims they have made. He said that within 4-6 months, they expect to have built a small battery facility in Oak Ridge and prototypes. On May 24, 2023 (Sequire Presentation) Dennis stated that revenue can start to be substantial in 6-9 months.
In late 2022, BioLargo added Christina Bray to their board of directors. She is the CEO of an electric vehicle charging company (BlueDot Energies). Christina Bray PR
BETI is very new and the available proven details are relatively sparse compared to some of the other parts of BioLargo's portfolio. Seems like a lot of potential, but more must be shown.




Clyra Medical

Clyra Medical is a bit surprising on the surface. What is an environmental engineering company doing in the medical field? The original inventor at the company (Kenneth Code) sought to create a chemistry that would help be helpful in infection control, as that was something his father was struggling with at the time. The result was a copper-iodine complex, which is very similar to the baseline chemistry that ONM Environmental uses for CupriDyne Clean in the ONM Environmental division.
Clyra Medical was formed so that the subsidiary could raise its own capital, independently of BioLargo. It is an asset that is 58% owned by BioLargo. Recently, Clyra has been selling shares to fund production of their first product that has 510k clearance from the FDA, BioClynse. BioClynse Product Brochure
https://preview.redd.it/zk8qgnl3qs1b1.png?width=697&format=png&auto=webp&s=a0192692321eb6a3a68013b7fc0861dfd5f3ecb6
BioClynse produces a very strong oxidation reaction, much like how CupriDyne does for odoVOC control. BioClynse is for use during surgery for infection control and can be used after the fact if a knee or hip replacement gets infected following a procedure. The product is gentle enough to be left in the body when the patient is sewn up and provides lasting infection control, including disruption of biofilm. No rinse is required, which is unique.
Other products that came to market and were successful across the last decade are starting to come into question because of toxicity concerns to tissue. The company believes that not only has the wound irrigation market expanded dramatically and will continue to, but that it is no longer being met by incumbent products.
Regarding BioClynse Efficacy and FDA Point-Of-View:
"The questions they asked us were 'You must be lying, because this has never happened before.' When we finally got through, it took us another $1.8M and about 2 years from that first moment, the reviewer said 'This is the lowest concentration of antimicrobial at this level of performance that the agency has ever seen.' And therein lies the special thing that we've been talking about since we started this company (Clyra), and it's now finally positioned to be in a very significant commercial role."
https://preview.redd.it/bbo6s81bqs1b1.png?width=846&format=png&auto=webp&s=387eee83e060b6523a257939a9addfeb93b7a606
BioClynse is expected to begin selling more substantially to orthopedic surgeons in Q2 and Q3. They have entered into a production agreement and are in negotiations with distribution partners (Clyra Production Agreement). Capital is being used to fund production. They have spent 2022 and the first parts of 2023 building out a sales rep network and “showing off” the product at industry events with significant positive response according to the company.
https://preview.redd.it/jf3eqdfeqs1b1.png?width=618&format=png&auto=webp&s=8a6b6858f2b871c71e9407d0189b32dd5dd5a8d2
Clyra Medical’s goal is to build up the company and to be spun off with the sale of Clyra to a larger medical company. Recently, capital has been raised around a $32M valuation (Reported during Q2 2022 Earnings Call, so may have changed a bit since then). As a subsidiary with just the very beginnings of commercial activity, I don’t anticipate that any spin-off would happen anytime soon, but if 2023 is the year they go commercial with a high margin product like BioClynse, that clock should begin and become less of a theory than it has been.
Regarding Future Product Development and Coronavirus Allowance:
"We were given notice of allowance for use of Clyra against coronavirus. Coronavirus is a very broad category, not just Covid, it's Middle-Eastern, SARS, it's everything, probably 300 different variations of upper respritory infections and lung disease. That opens up the pathway for us to pursue drug applications for nebulizer therapy, inhalant therapy, nasal sprays, throat sprays, and have good IP coverage. This is good IP coverage. We were denied 4 times. We kept going back and fighting for this, and finally the patent office said: You know what, you got it. They gave us a very broad allowance, and we're going to continue to expand on that. That has major implications in a drug pathway for these Clyra products, which we've always believed the tough part wasgetting the patent done, but we have that."
Clyra Medical added 2 members to their board in 2022. Clyra Board Additions. Nick Valeriani spent 34 years at Johnson and Johnson, particularly with wound control (Neosporin). Nick serves on the board of $50B-valued Edwards Lifesciences ($EW). Linda Park is the Senior Vice President, Associate General Counsel, and Corporate Secretary for Edwards Lifesciences. She also joined as a member of the BioLargo board. It has been stated that Linda has been brought on partially for her expertise and guidance as BioLargo seeks to uplist in future to a national market like the Nasdaq.
Clyra Medical incurred a loss of $1.38M in 2022, bringing in just $56k what was essentially a few initial users of BioClynse in a professional setting.



BLEST Technologies and Projects

Garratt-Callahan – Minimal Liquid Discharge (MLD) Devices
In 2021, BioLargo announced that Garratt Callahan (largest private water company in North America) approached them to ask for help finalizing the design of their Minimal Liquid Discharge technology. GC MLD Announcement BioLargo helped them finish the design and will serve as the manufacturer of the product. The product has patent coverage through Garratt Callahan. GC MLD Patent
The MLD systems are water reuse devices that take the mineral content out of water streams for use in things like cooling towers. The devices allow for an industrial water user to stretch their water budget significantly further, bringing value to clients in both reducing their water costs, but also allowing them to continue their planned operations in an environment where water availability may fluctuate based on hydrologic/drought conditions. Potential clients would be data centers, energy generation, and industrial water users.
BioLargo will make money from the manufacturing and sale of the unit (approximately $500k per unit), while Garratt Callahan will make their money from the operation of the machines.
It was expected that these units would begin being sold in 2022, however that did not happen. A factory acceptance test was successfully completed in February of 2022 ("FAT" Acceptance) , however contracts have not been announced BioLargo maintains confidence in the future of these devices and states that they are involved with a dozen or more negotiations and design work for potential projects. If those projects are confirmed, GC MLD devices can be a strong revenue stream through an established water treatment company.
GC maintains that 30-50 units can be moved annually, but that is hard to predict when the first one will be sold and if 30-50 per year is a reasonable expectation given the delayed rollout. If they can accomplish that, however, it would bring in $15M-$25M annually.
https://preview.redd.it/ra8cj3emqs1b1.png?width=975&format=png&auto=webp&s=90fa9a91bab9ff455d88bafea6089d419df5f038
Garratt Callahan has also agreed to sell AEC for PFAS remediation (discussed below). BioLargo has stated that a few of their potential PFAS remediation projects expected to move forward soon are ones that GC brought to the table.



Ultra Safe Nuclear Corporation – Fuel Production Design Work
Ultra Safe Nuclear Corporation (USNC) is designing micro-modular nuclear reactors. Part of that design is a new fuel system (FCM/TRISO-fuel). They have contracted BioLargo Engineering to help design their fuel production facility in Oak Ridge, Tennesse (also where BLEST is headquartered) which opened in August 2022. Fuel Production Facility - USNC/BLEST Collaboration - Pilot Fuel Manufacturing Facility Opens - FCM/TRISO Fuel Information
https://preview.redd.it/2dasi4sqqs1b1.png?width=931&format=png&auto=webp&s=18d66bd7b496d857ab80b3b247b2aa62faa6ee25
Phase 1 of the project was completed. Phase 2 has gotten a verbal “yes”, but a signed contract has not been announced officially yet.
April 24, 2023 Prospectus
"In the second quarter of 2022, BLEST was contracted by Ultra Safe Nuclear to assist in producing the first prototype fuel production systems for their new nuclear reactor called the Micro Modular Reactor (MMR®). Ultra Safe Nuclear is a Seattle-based nuclear energy company that has invented a “fission battery” - a fourth generation modular nuclear reactor – that can deliver safe, zero-carbon, cost-effective energy anywhere. The MMR® uses ceramic-encapsulated nuclear fuel – Fully Ceramic Micro-encapsulated (FCM+++) – an extremely rugged and stable fuel with high temperature stability. BioLargo has been retained to provide engineering design support, fabrication, and integration for the company’s prototype fuel production systems. Because of the success of the early phase of the project, this project is expected to expand over the coming months in scope and significance to BioLargo, making them an important customer for BLEST."



Waste to Energy – Design Work
BioLargo was contracted to begin design work on a waste to energy conversion project in South America. The facility being designed would be the largest waste-to-energy conversion plant in the world if it goes to its full scale. The project has 10 years of planning and preparation behind it. The project would be 6 phases, and the company has estimated that all 6 phases would be around $50M in design work.
Waste to Energy PR
The first phase was a feasibility study and was completed. BioLargo has given a proposal for Phase 2 and is awaiting the green light from the client. The timeline to begin Phase 2 has been slower than originally expected (as seen in June 2022 image below). On the last call, there was mention of political instability in South America giving some pause to decision-making at this time, but the BioLargo continues to maintain that they are in good standing with the client and the project is in good standing overall. The client has brought 4 more projects to BioLargo in Southeast Asia.

“This developer has actually brought us 4 more projects. This one has moved from Phase 1 to Phase 2. Phase 2 will push over $1 million. Phase 3 will probably be in the $7.5 million range.”

“In April 2022, our engineering subsidiary was hired by a Southern California based sustainable energy services company to conduct a comprehensive project plan (i.e., “feasibility study”) for a waste-to-energy (WTE) conversion plant in South America – one of multiple projects in planning stages by the company. Our engineers completed the initial feasibility study and have delivered a proposal for the next phase of the project (front end engineering design, aka FEED). The client has also requested feasibility studies and a FEED proposal for WTE plants in Asia.”
From June 2022 Annual Shareholder's Meeting - note: Stage 1 is complete. Stage 2 has not begun.


PFAS Remediation:

The Aqueous Electrostatic Concentrator (AEC) is likely the biggest opportunity in the BLEST portfolio. BioLargo has one active project that has been contracted for PFAS remediation. They are awaiting approval from the client to begin the next phase and scale towards a full installation. During a May 24, 2023 (day of making this post) presentation with Sequire, Dennis mentioned that Phase 1 is complete and they are expecting to move to Phase 2 in the near future. Phase 2 would be $500k-$1M and would take 6-9 months. Phase 3 to go to full scale would be a $15M-$20M in expected revenue. It would also provide a full-scale installation to lean on for proof of function and scaling for clients to have confidence in.
AEC is a PFAS collection technology. PFAS “Forever Chemicals” are compounds that are designed to not break down through natural processes. The EPA is in the process of setting drinking water standards for PFAS that would impact 65,000 drinking water systems across the country. Incumbent technologies (Granular Activated Carbon and Ion Exchange Resin) face performance and regulatory challenges moving forward as the EPA’s proposed regulations come closer to taking effect.
In March 2023, they proposed federal drinking water standards of 4ppt for PFOS and PFOA (the two main compounds), and a combined weighted limit for 4 other PFAS compounds based on their health advisories. The regulations are expected to firm up in the coming months after necessary comment periods and EPA process etc. Federal Proposal
PFAS waste is on a trajectory to be designated as HazMat under CERCLA (HazMat Classification). When used for municipal drinking water remediation, incumbent technologies produce several tons of PFAS-laden carbon or PFAS-laden resin. Recently, Cape Fear removed almost 200 tons of PFAS-laden carbon waste from their facility (Cape Fear Waste). Cape Fear is a very large system, but even a mid-size municipal system ends up having to consider the liability of that amount of HazMat waste on a recurring basis. That “changeout period” becomes more frequent when the drinking water standards get lower.

At 9.6ng/L, the data in the right column has too high PFAS concentration to pass proposed federal limits. 4ng/L and the detection limit are very similar levels of PFAS contamination (1-2ng/L is consistent detection limit usually). 2.7-7.1 Month range for GAC and IX technologies (standard incumbents). Lower regulatory standards will require more frequent changeout of media.
The media used for GAC projects can be regenerated. Ion exchange media cannot be regenerated. GAC waste can only be regenerated for future use in some parts of the United States. The legality of that process has come into question due to concerns about releasing PFAS emissions into the air (DoD Incineration/Regeneration Ban). Some users continue to regenerate the material while the EPA goes through the process to regulate PFAS.
If regeneration is not allowed, the material will end up requiring HazMat landfilling and not be able to be regenerated for future use. That will make remediation with GAC much more complicated and expensive. It will increase the total cost of changing out carbon material by requiring more new material to be used, but also increasing disposal costs of waste. Several tons of waste (200 tons in Cape Fear) now need to be sent to a HazMat landfill.

How Many Municipal Drinking Water PFAS Remediation Projects Will be Necessary?: West Virginia recently tested 37 water systems. 19 of them would be out of federal compliance if the proposed federal standards were implemented (WV PFAS Testing). 37 systems is not a huge sample size, but this is reasonable when compared to what I have found when looking at other state-level data across the country.
If 50% of systems require remediation, that is around 32k projects just for drinking water. For reference, if there are 32k projects for half of the US population that require remediation, the average number of residents served by a system is just over 5,000, though that number will have quite a large range with some water systems serving hundreds of thousand residents..
PFAS Remediation Project Examples: In Dover, New Hampshire, a 1.1M gallon per day facility was approved for $13.9M. This was for the treatment of half of the water supply for a population of 33,000 residents. (Dover Project Details)
The project for Wausau has a cost estimate of $23M (Wausau Cost Estimate). Wausau Water serves 16000 customers (40,000 residents) and treats just over 4M gallons of water per day (Wausau Customer and Daily Flow).
Cape Fear, NC has $43M up front costs with $5M annual costs to operate (Cape Fear Costs). The facility is 44M gallons per day (Cape Fear - Size).

Municipal Water PFAS Remediation Cost Estimate: Municipal drinking water projects are generally $5-$50M caliber projects. Small town projects can be $1M-$5M, and the largest projects will end up being over $100M.
Before the federal Orange County Water District (1% of the population of the United States) estimates a total of $1B will be required for the remediation of their water systems (OCWD Estimate). That is a figure from 2020 and is expected to have increased since then.
If you use Orange County’s estimate across the United States, it will cost over $100B for municipal drinking water.
The EPA estimates that PFAS remediation will cost between $769M and $1.2B annually (EPA Estimate). American Water Works Association (AWWA) estimates up to $2.9B annually (AWWA Estimate).

What About PFAS Remediation Outside of Municipal Drinking Water? I won’t attempt to do the same thing for other water treatment sectors. You'd probably stop reading if you don't already want to. It is important to note that drinking water is only part of what will require PFAS remediation projects.
Industrial water users (landfills, oil/gas, papepulp production, metal processing/finishing, wastewater treatment facilities) will require remediation equipment.
Groundwater remediation takes place when there is a contaminated aquifer due to a spill or through things like spreading biosolids from wastewater treatment plants on farmland. If the biosolids have PFAS in them (which many do), then the groundwater is contaminated because the PFAS has been applied across the soils.
Surface water remediation can be required if high levels of PFAS are found. It isn’t clear what the EPA is planning to do with surface water, but some states have attempted to set concentration limits.
Many of the specifics still need to be firmed up by the EPA, but in general it is safe to assume that the estimated $769M-$2.9B that is estimated for PFAS remediation of municipal drinking water annually will not begin to represent the total cost of PFAS remediation in the United States.
Any company that has leading PFAS remediation technology has the opportunity to tap into a gigantic emerging market that is going to be backed by federally enforceable drinking water standards.

Aqueous Electrostatic Concentrator (AEC):

AEC Product Video - BioLargo's PFAS Website - AEC Product Brochure
AEC functions by running water across (not through) a membrane while applying electric charge. PFAS compounds are fused to the membrane and removed from the water supply. AEC only removes the PFAS compounds, which is unique for collection technologies. Materials like granular activated carbon remove all contaminants, meaning that it is very inefficient for PFAS removal since PFAS is found in such low concentrations. This is important because remediation using GAC will produce much more waste than it will with AEC (up to 1000x depending on specific water chemistry). A user of AEC doesn’t have to worry about managing several dozen tons of waste every changeout period.
Tonya Chandler on AEC Footprint and Waste Production vs. Incumbent Technologies:
How do we measure up size-wise? Well, fairly similar to a GAC system. The difference is that when you see all of our frames, I don’t need to be skidded. I could line the walls with those frames. I can drop those frames – we’ve got one customer that wants to drop them into a pit that’s in their system that they don’t use anymore. I can stack them on top of each other to create space. As long as I have maintenance room around them, I’m pretty flexible on the layout. But you’ll see I produce much less spent (media). Now, also note that that GAC number that I’m giving you there is a single pass. I’m not considering a lead-lag in that number.
GAC vs AEC Waste and Footprint Comparison – note: AEC changeout period is expected to be longer than GAC changeout period. Disposal when spent does not represent the same period of time.
Orange County Water District - AEC can produce \"Non-Detect\" results all 27 tested PFAS compounds.
Tonya Chandler on AEC Origin, Design and Function:
“The AEC stands for the Aqueous Electrostatic Concentrator, and they decided that they wanted to use the polarity of the PFAS against it. The hypothesis was that if they created some chambers that had a series of electrodes and some specialized membranes, they might be able to pull the PFAS out and create a concentrated stream. The goal was to produce a stream that met the standards. They thought, ‘well if we did multiple stages, we could probably create DI-water. They wanted to stay low energy, and they wanted the cost to be affordable.
What they found was not what they expected. When we did the initial testing on this, they found that no concentrated stream existed, although we were removing the PFAS, we weren’t finding it in the anode stream. They were able to remove 99% of the PFAS in a single pass through the system. They got a side benefit of low-energy desalination in all of this, and they got their low cost at about 30 cents per 1000 gallons.
The biggest concern for us was why we didn’t create a concentrated stream. What we found was that we were literally ripping the PFAS out of the water, and when they came in contact with the membrane that we have in there, it fused to the membrane, and once it fused to the membrane, PFAS fuses to itself, so we were able to create a system that all of the PFAS stayed on the membrane but we were able to get very high concentrations of PFAS on the membrane before it was spent.”

From September 2022 Tonya Chandler Presentation to Wisconsin Engineers
From 2023 10-Q Report:
“We have successfully validated the AEC as an effective system to selectively extract and collect PFAS chemicals from contaminated water including performance testing that shows “non-detect” levels of removal, which meets new EPA standards. We have demonstrated more than nine months of continuous operation showing no materially significant degradation of the AEC system’s components or performance over time. As a modular system, we believe the AEC is scalable to a commercial scale, and we believe that our engineering team has the experience to deliver systems to meet the needs of a commercial installation."

Dennis on Small Commercial-Scale AEC units:
"These are new – we have three of these. We just got – just built and what will happen with these machines is they go out into the field where we go through early testing program. We identify a spot, where we can work with a client the customer, and we say, let's as an additional step just to make sure, let's bring one of these out, park it into their location for three or four weeks, run some samples, run some tests and show our customer, our prospective customer that says that, the device can be well suited for the custom circumstances that surround that customer's water source.”

https://preview.redd.it/k1mkmv680t1b1.png?width=975&format=png&auto=webp&s=dca6291bd1bfb510ffabffbe3b1dcbdaab0dea37
submitted by davethebear612 to trakstocks [link] [comments]


2023.04.20 00:41 jhpratt2 $nwbo- Mulholland 4/10/23 Times article/ NYAS 5/2/23 - LIAU-UCLA-SPORE combo presentation ?

“The average survival for glioblastoma is nine months,” he says. It is perhaps surprising, then, to hear Mulholland insist: “I’m actually very optimistic that we will cure it, and it could be very soon.” (Times-5/10/23)
Mulholland saying he knows of a cure for GBM.See quote above from the 4/10/23 Times article.He is also saying he wants the UK to start 12 combo trials each year. For the next 5 years ? Is that 60 combo trials ? I assume each one will have DC VAX L as a component.Also, it sounds as Mulholland wants the U.K. to pay for all the combo trials. Do you know if Mulholland is speaking on 5/2 at the NYAS ? Recall he spoke 5/10/22 at the Boston Massacre. Thanks.A.E.K.
Member Level Re: ae kusterer post# 587059
Wednesday, April 19, 2023 6:00:28 PM
Post# 587068 of 587077 Mulholland was also a doctor on the Checkmate trial, and published results thereof, by BMY, which failed. So he has been on multiple GBM trials, BP as well as tiny NWBO.
He chose to present the results for DCVax-L. Doubtful he’d have done so had he any doubts and there is a lot yet to do with DCVax-L. He was a great advocate, though certain interests did their best to distract in the lead up to and immediate after period of that 5/10 presentation.
He seems very dedicated and plugged in on the effort in the UK to address GBM and advance treatments.
ae kusterer
Re: None
Wednesday, April 19, 2023 5:17:04 PM
Post# 587059 of 587079 dstock07734: Liau, Mulholland, and I am sure other significants, want to see combo trials start as soon as possible.It appears DC VAX L combo trials are the topic of discussion at 9:40 a.m. on 5/2/23 at the NYAS (https://events.nyas.org/event/b42eef99-1a18-41dc-9322-17c52d483a4a/websitePage:ccf12eed-4b47-487c-82af-faa589df6e0a). As of yet, the speaker is unannounced. WHY ? Maybe everyone is afraid that the Boston Globe-Stat News flu will break out again .
Member Level Re: ae kusterer post# 587050
https://.advfn.com/boards/read_msg.aspx?message_id=171727544
Wednesday, April 19, 2023 5:09:43 PM
Post# 587057 of 587059 AE,
Is there supposed to be a combo trial in human for this fiscal year?
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171727376) :
Mulholland is one of the lead investigators in the DC VAX L phase 3 trial. He was LIau's stand in 5/10/22 when she was incapacitated by covid or the Stat News- Boston Globe flu. In this 4/10/23 TIMES article he is suggesting 12 trials , with 16 patients each ,each year, to test UCLA-SPORE-LIAU combinations. He thinks one or more of such combinations could be cures for GBM . It is unlikely the public can understand the subtleties of this article. Implicit in Mulholland's "cure" contention are MAA and NICE approvals for DC VAX L . Mulholland wants Britain to fund the 12 trials annually to move everything along a toute vitesse . The U.K sees programs such as Sawston enabling it to supersede the U.S.in cancer therapy breakthroughs. England sees an opportunity to do this because it believes the FDA is mired in politics and bureaucracy. https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
TO BE FEATURED AT 9:40 A.M. , 5/2/23 AT NYAS ?
https://trp.cancer.gov/spores/abstracts/ucla_brain.htm Project 1: Targeting immunotherapy-induced resistance with DC vaccination and immune modulation Project Co-Leaders: Robert M. Prins, PhD (Basic Science Leader) Linda M. Liau, MD, PhD, MBA (Clinical Science Leader)
The overall goals of this project are to investigate mechanisms of immune evasion following treatment with dendritic cell (DC) vaccines, and to develop rational combinations of immunotherapeutic strategies to overcome the immunosuppressive milieu of the brain tumor microenvironment. We previously found that, in addition to inducing T-cell infiltration into brain tumors, DC vaccination + anti-PD1 blockade may also create a pro-inflammatory environment within the tumor that induces the immigration of immunosuppressive myeloid cells (TIM). TIM are phenotypically similar to the myeloid cells that attenuate the T-cell response to chronic viral infections, and may counteract the anti-tumor T-cell responses induced by DC vaccination. Therapies that target myeloid cells within the tumor microenvironment represent a promising new strategy. As such, inhibition of these myeloid cells using a CSF-1R inhibitor, in conjunction with autologous tumor lysate-pulsed DC vaccination (ATL-DC) and PD-1 mAb blockade, resulted in significantly prolonged survival in tumor-bearing animals with large, well-established intracranial gliomas. Our hypothesis is that myeloid cells mediate adaptive immune resistance in response to T-cell activation induced by immunotherapy. We have planned a series of novel pre-clinical studies to re-polarize myeloid cells, to optimize how the timing and sequence of immunotherapy can influence ant-tumor immunity, and a new clinical trial to test the first-in-human combination of a new brain penetrant CSF-1R inhibitor (CSF-1Ri; PLX3397, Daiichi-Sankyo) with DC vaccination and PD-1 mAb blockade (Pembrolizumab, Merck) in patients with newly diagnosed GBM. A better understanding of the biology of these cellular interactions will provide insight into more effective ways to induce therapeutic anti-tumor immune responses for this deadly type of brain tumor.
TIMES 4/10/23 ARTICLE ; MULHOLLAND IS THE FEATURED NEUROSURGEON .
(https://www.thetimes.co.uk/article/brain-cancer-that-affects-3-200-patients-a-year-could-be-cured-with-trials-6dz5sf5l5) Expert urges drug trial that could lead to cure for most common brain cancer Survival rates for the disease that killed Tessa Jowell are poor. Now a Labour MP whose sister was diagnosed with glioblastoma is calling for action after a specialist said sufferers were being neglected by the medical establishment Tessa Jowell, with her Dame Commander insignia in 2013, died of the disease in 2018
“I’m not a woman given to crying in public. I’m a bit old. I’m not part of that generation which emotes and talks about personal stuff,” says Siobhain McDonagh, the Labour MP. “It doesn’t feel that comfortable.”
In a moving speech in the Commons last month, her voice broke as she described being there when her sister, Margaret McDonagh, collapsed at a party in November 2021, and was rushed to hospital in an ambulance. The peer was diagnosed with glioblastoma, the most common form of brain tumour. It is the disease that killed the Labour former cabinet minister Tessa Jowell in 2018.
The MP decided public discomfort was a “price worth paying” in a campaign to improve the chances of brain tumour patients like her sister via opportunities to take part in research and better training for NHS doctors.
Siobhain McDonagh gave a moving speech in the Commons about the disease last month
What is currently the “gold standard” treatment for glioblastoma on the NHS “shouldn’t even be called a plastic standard”, she says.
The 3,200 people diagnosed with glioblastoma in the UK each year follow a well-worn trail. First, surgery to remove as much of the tumour as possible. Then, if they are well enough, radiotherapy. Then chemotherapy, with a drug called temozolomide, first trialled in the 1970s. Many die before completing treatment.
McDonagh was too unwell to withstand the chemotherapy. The family have sought private care from Dr Paul Mulholland, a specialist in glioblastoma at University College Hospital (UCH), London.
He has put her on a regime of immunotherapies and hyperthermic treatment, which involves raising the temperature around the tumour in an attempt to boost the drug’s efficacy.
Margaret McDonagh first had to travel to Germany for the treatment she requires Margaret McDonagh first had to travel to Germany for the treatment she requires RICHARD GARDNEREX/SHUTTERSTOCK Siobhain McDonagh had to take her sister to Germany for the hyperthermic treatment, before Mulholland got a machine to deliver it in London, sometimes fearing they would not be allowed on board the plane because Margaret was so unwell.
As glioblastoma patients go, they are “on the lucky end”, she insists, with a good support network, the option of private treatment and a reasonably swift diagnosis.
Even so, it is “a struggle”. She has to pause a number of times while speaking to The Times to take calls resolving a problem with the company that is supposed to be delivering drugs for her sister.
“I want everybody to have the options I’ve had, but I don’t want them to be as difficult,” McDonagh says.
Siobhain McDonagh with Dr Paul Mulholland, the brain cancer specialist treating her sister, who says patients are being neglected and there must be more clinical trials for patients and more doctors trained Siobhain McDonagh with Dr Paul Mulholland, the brain cancer specialist treating her sister, who says patients are being neglected and there must be more clinical trials for patients and more doctors trained TIMES PHOTOGRAPHER JACK HILL She asked ministers to get 200 sufferers a year access to a trial and commit to medical oncologists being trained on brain tumours.
Patients newly diagnosed with glioblastoma “go on their smartphone and they google it”, says Mulholland. The words that stare back at them are “death, dying, terminal”.
“The average survival for glioblastoma is nine months,” he says. It is perhaps surprising, then, to hear Mulholland insist: “I’m actually very optimistic that we will cure it, and it could be very soon.”
A push on getting patients into clinical trials, and more training for young doctors in the disease, the most common form of brain tumour, could pay rapid dividends, he says.
There have been few advances in care in decades because patients are being “neglected” by the medical establishment and pharmaceutical industry, Mulholland says bluntly.
The number of patients with glioblastoma, which he sees as an “absolute epidemic, shocking epidemic”, is nonetheless “not enough for a business case” to encourage companies to test their new drugs against the cancer.
Doctors training to become medical oncologists, specialists in using drugs to treat cancers and in clinical trials, are not required to spend any time at all training in brain cancer.
Although, Mulholland notes: “They do a year of bowel cancer and so they have to do six months of lower bowel cancer and six months of upper bowel cancer. So people can ponder that.”
The NHS does not require medical oncologists to be present at the multidisciplinary team meetings discussing patients with glioblastoma, so the people most likely to know about the few clinical trials of new treatments are not in the room when decisions are being made about patients’ options.
ADVERTISEMENT
That all needs to change, Mulholland says. “I think that we need to make a commitment, as a country, that we put 200 glioblastoma patients into a trial [each year] that might change the outcome of their disease.
“I don’t mean a trial where you give them a little bit of cannabis to see if it makes them [feel] better. I mean, a real drug that might cure the disease.”
There are good reasons to think that immunotherapies called checkpoint inhibitors, which target the complex neighbourhood of cells in and around a tumour, should help in glioblastoma. Mulholland is confident using them in his private practice for patients like Margaret.
But the drugs are expensive, he says. “People do have more choices if they’ve got health insurance. And that’s not a position that makes me comfortable. And that’s why I want to do these trials, so that we’re not in this position. So I want to get real data in real trials, and offer people good treatment. And it would be then, when we’ve got good data, we can treat people in the NHS.”
The target of 200 patients is very achievable, Mulholland says, suggesting they be put in groups of 12 initially, to try different treatment combinations, going on to broader trials in those that seem to work.
Patients and families are “shocked” at their lack of options, he says. “People start searching for these trials that aren’t there. They’re up, they are awake at three o’clock in the morning looking for their relatives’ trials, and then they come and show me and I say, ‘But that’s not brain cancer. That’s for breast cancer. That’s for this, that for that . . .’
“I know what’s there. They really are looking for the needle in the haystack. There are very, very few trial opportunities for patients.”
ADVERTISEMENT
Mulholland recently ran a trial of immunotherapy in 119 glioblastoma patients at UCH, the results of which will be announced at an American Society for Clinical Oncology conference in Chicago this year. But The National Brain Appeal charity had to step in to provide funding because he could not get it elsewhere.
He is now recruiting for a new trial. It aims to try immunotherapy before surgery, and so requires patients to come forward very soon after diagnosis. Interested people should ask their doctors and nurses to contact his team at UCH.
“If you want a different survival [rate], you’re going to have to do something different,” Mullholland says. “You can’t just keep repeating the same thing.”
COMMENTS:
Comments are subject to our community standards and participation guidelines policy, which can be viewed here. By joining the conversation you are accepting our community rules and terms. Update your commenting notification settings here. Our policy is for readers to use their real names when commenting, find out more here. joe pratt
Sort by
Recommended A Smith 10 APRIL, 2023
This article is shocking. Where are the comments from NHS England and NICE? Both of them have questions to answer.
Reply
Recommend (60)
Share A Collins 10 APRIL, 2023
Please can the subeditor for this article have a good think about whether the headline is appropriate. To me, it seems to sensationalise the piece. The story in the body of the text is that Glioblastoma Multiforme (GBM) is still a rotten diagnosis with an average prognosis of 9 months of poor healt...
See more
Reply
Recommend (36)
Share Chris Bolton 10 APRIL, 2023
This headline is typical of The Times. Headlines are designed to encourage people to read the article, and the headline writer doesn't seem to care whether they're accurate. There's no point getting people to read the article if they then stop subscribing to the paper.
Reply
Recommend (5)
Share S harris 10 APRIL, 2023
The lack of research into this cancer is shocking.
Reply
Recommend (35)
Share Richard Smith 10 APRIL, 2023
A good friend of mine died of this in his early 50's. He had surgery which seemed to slow it down for a while, and then immunotherapy, but it came back a few months later.
The stats are absolutely awful. I remember telling a work colleague at the time I found out about his diagnosis and his reply w...
See more
Reply
Recommend (25)
Share Jimmy P 10 APRIL, 2023
The headline is a little misleading, there is little to suggest that trials can cure glioblastoma, at least in the short or medium term. Also misleading to suggest that immune checkpoint inhibitors are the answer - while v effective in melanoma, renal cell carcinoma, some lung cancer - they are of ...
See more
Reply
Recommend (24)
Share Sahra Durnford 10 APRIL, 2023
Agree. Reads more like an advertorial for expensive treatments with limited and unproven efficacy.
Reply
Recommend (7)
Share Emily Chatwin 10 APRIL, 2023
This is the disease that killed my Aunt when she was in her 40',s and my father in his early 70's, so I devoured this article the headline with its "could be cured with trials" is an absolute journalistic disgrace.
Reply
Recommend (17)
Share L I Shigaev 10 APRIL, 2023
I am sorry for your loss, thank you for sharing.
As for this piece, in particular the headline, I feel as though I have gone through a similar emotional journey to you as I went from headline through the article. I’m feeling quite low now, with my hope having been dashed
Reply
Recommend (4)
Share Mick Mahon 10 APRIL, 2023
Read this click bait article thinking it was going to describe new treatments to cure this evil thing that brutalised & took the love of my life before her 50th birthday. Why would ToL publish such a shabby hopeful headline then go on to confirm there is no new glioblastoma multiform treatment and ...
See more
Reply
Recommend (12)
Share N Lancaster 10 APRIL, 2023
My sister died of it in 2019. She was always hopeful of finding an alternative "treatment" to what she got. It only prolonged her discomfort.
Reply
Recommended (0)
Share Alan Mowle 10 APRIL, 2023
The problem is really, really skilled Doctors. The treatment Dr.Mullholand used with the hyperthermic approach, is delicate and time consuming and needs the right machine to increase the temperature around the cancer tissue, and get an enhanced anti-cancer response from the immunotherapy drugs. Tim...
See more
Reply
Recommend (12)
Share Anne Chitnis 10 APRIL, 2023
My son died in the seventies from “a deep and silent” brain tumour, aged seven years old. It doesn’t seem to me that treatment has advanced at all since then. As for other cancers, such as breast cancer or prostate cancer, the research goes where the money is. We all have a father, perhaps vuln...
See more
Reply
Recommend (9)
Share Rob Parkes 10 APRIL, 2023
Where should one put research funds?
Into rare tumours that affect very few people or common problems that affect and would benefit large numbers.
Reply
Recommend (2)
Share
1 reply James Robinson 10 APRIL, 2023
There are well over a 100 different forms of brain tumour - some benign and curable, some benign but dangerous and some cancerous that could spread. They disproportionately affect younger people and children, but research expenditure is shocking and the treatment often brutal.
I really hope the opt...
See more
Reply
Recommend (6)
Share H D Lewis 10 APRIL, 2023
Another area of shame for the UK. But will resources be put into this?
Reply
Recommend (5)
Share Rob Parkes 10 APRIL, 2023
Research is done world wide so it is not 'just down to the UK' to solve it.
Reply
Recommend (2)
Share Nicolas Crowhurstt 10 APRIL, 2023
Why is it that the ad in the article saying first symptoms of a brain tumour has absolutely nothing about a brain tumour?
Does the Times even check what it's ads say?
Reply
Recommend (4)
Share Norman Goldner 10 APRIL, 2023
we are getting closer and closer to better treatments and then cures for cancer. Development of the mRNA vaccine for COVID opened up new research routes that will lead to new treatments, which hopefully will be here by the end of the decade.
Thank you to the scientists who are making this possible. ...
See more
Reply
Recommend (3)
Share Michael Lingard 10 APRIL, 2023
We must remember that most research is funded by the pharmaceutical companies and that they rank as the most profitable companies on the stock exchange. There has to be a better way of funding medical research than what is likely to be the most profitable new drug when other therapeutic approaches ...
See more
Reply
Recommend (2)
Share Ann Jackson 10 APRIL, 2023
Please G-d
Reply
Recommend (1)
Share Patrick Moffat 11 APRIL, 2023
I don’t mean a trial where you give them a little bit of cannabis to see if it makes them [feel] better. I mean, a real drug that might cure the disease.
This appears to be a snide and somewhat disingenuous reference to a trial overseen by Professor Susan Short, chief oncologist at Leeds university....
See more
Reply
Recommend (1)
Share N Morris 10 APRIL, 2023
Nothing much for ocular melanoma either. Prognosis after mets to liver? Six months
Reply
Recommend (1)
Share Virginia Crook 10 APRIL, 2023
Please, Times, why do I have to keep “signing up to post” when I’ve been doing it since 2019!
Reply
Recommend (1)
Share Katherine Barnes 11 APRIL, 2023
I agree it’s quite distressing to read that there could be a cure I’ve just lost my husband to glioblastoma. But yes to more research and clinical trials please so people have longer and more hope.
Reply
Recommend (1)
Share Ryan Meade 11 APRIL, 2023
My best friend passed away from a Glioblastoma tumour in 2014 at the age of 27. He got 4 years after his diagnosis mostly thanks to Dr Charlie Teo agreeing to do his surgery for free so soon after his diagnosis. Thoughts go out to anyone to have had friends or family succumb to this awful disease a...
See more
Reply
Recommended (0)
Share Hugh Duncan 10 APRIL, 2023
I was a Labour party member in SW19 in the 1980s and used to know both Margaret and Siobhan - Both great and friendly people.
Greatly sad to hear of Margaret's condition.
I'm surprised though that Siobhan has managed to keep her plain normality (and her attractiveness if one is allowed to say that...
Mick Mahon 10 APRIL, 2023 Read this click bait article thinking it was going to describe new treatments to cure this evil thing that brutalised & took the love of my life before her 50th birthday. Why would ToL publish such a shabby hopeful headline then go on to confirm there is no new glioblastoma multiform treatment and no new hope in the near or long term future! The sad fact is that nothing has changed - that should have been the headline! The treatment remains the same as it’s always been - cut, nuke, poison the tumour and repeat until the patient can endure no more. The treatment compounding the debilitating pain & grim misery of being turned into a vegetable by the brutal medical assault on the brain and body during the short few weeks / months of a living hell!
COMMENTS:
Jimmy P 10 APRIL, 2023 The headline is a little misleading, there is little to suggest that trials can cure glioblastoma, at least in the short or medium term. Also misleading to suggest that immune checkpoint inhibitors are the answer - while v effective in melanoma, renal cell carcinoma, some lung cancer - they are of modest benefit in other cancers. As for therapeutic hyperthermia etc available in Germany, little robust data to support their use. While there is research in GBM, clearly it is dwarfed by that in breast cancer, prostate cancer. Not sure how that can be redressed.
That all needs to change, Mulholland says. “I think that we need to make a commitment, as a country, that we put 200 glioblastoma patients into a trial [each year] that might change the outcome of their disease.
“The average survival for glioblastoma is nine months,” he says. It is perhaps surprising, then, to hear Mulholland insist: “I’m actually very optimistic that we will cure it, and it could be very soon.”
"Expert urges drug trial that could lead to cure for most common brain cancer."
"The target of 200 patients is very achievable, Mulholland says, suggesting they be put in groups of 12 initially, to try different treatment combinations, going on to broader trials in those that seem to work."
submitted by jhpratt2 to NWBO [link] [comments]


2023.04.19 21:26 jhpratt2 $nwbo- 4/10/23-TIMES- Muholland-GBM CURES?

Mulholland is one of the lead investigators in the DC VAX L phase 3 trial. He was LIau's stand in 5/10/22 when she was in capacitated by covid or the Stat News- Boston Globe flu. In this 4/10/23 TIMES article he is suggesting 16 trials , with 12 patients each , to test UCLA-SPORE-LIAU combinations. He thinks one or more of such combinations could be cures for GBM . There is no way the public can understand the subtleties of this article. Implicit in Mulholland's "cure" contention are MAA and NICE approvals for DC VAX L . Mulholland wants Britain to fund the 16 trials to move everything along a toute vitesse . The U.K sees programs such as Sawston enabling it to supersede the U.S.in cancer therapy breakthroughs. England sees an opportunity to do this because it believes the FDA is mired in politics and bureaucracy. https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
TO BE FEATURED AT 9:40 A.M. , 5/2/23 AT NYAS ?
https://trp.cancer.gov/spores/abstracts/ucla_brain.htm Project 1: Targeting immunotherapy-induced resistance with DC vaccination and immune modulation Project Co-Leaders: Robert M. Prins, PhD (Basic Science Leader) Linda M. Liau, MD, PhD, MBA (Clinical Science Leader)
The overall goals of this project are to investigate mechanisms of immune evasion following treatment with dendritic cell (DC) vaccines, and to develop rational combinations of immunotherapeutic strategies to overcome the immunosuppressive milieu of the brain tumor microenvironment. We previously found that, in addition to inducing T-cell infiltration into brain tumors, DC vaccination + anti-PD1 blockade may also create a pro-inflammatory environment within the tumor that induces the immigration of immunosuppressive myeloid cells (TIM). TIM are phenotypically similar to the myeloid cells that attenuate the T-cell response to chronic viral infections, and may counteract the anti-tumor T-cell responses induced by DC vaccination. Therapies that target myeloid cells within the tumor microenvironment represent a promising new strategy. As such, inhibition of these myeloid cells using a CSF-1R inhibitor, in conjunction with autologous tumor lysate-pulsed DC vaccination (ATL-DC) and PD-1 mAb blockade, resulted in significantly prolonged survival in tumor-bearing animals with large, well-established intracranial gliomas. Our hypothesis is that myeloid cells mediate adaptive immune resistance in response to T-cell activation induced by immunotherapy. We have planned a series of novel pre-clinical studies to re-polarize myeloid cells, to optimize how the timing and sequence of immunotherapy can influence ant-tumor immunity, and a new clinical trial to test the first-in-human combination of a new brain penetrant CSF-1R inhibitor (CSF-1Ri; PLX3397, Daiichi-Sankyo) with DC vaccination and PD-1 mAb blockade (Pembrolizumab, Merck) in patients with newly diagnosed GBM. A better understanding of the biology of these cellular interactions will provide insight into more effective ways to induce therapeutic anti-tumor immune responses for this deadly type of brain tumor.
TIMES 4/10/23 ARTICLE ; MULHOLLAND IS THE FEATURED NEUROSURGEON .
(https://www.thetimes.co.uk/article/brain-cancer-that-affects-3-200-patients-a-year-could-be-cured-with-trials-6dz5sf5l5) Expert urges drug trial that could lead to cure for most common brain cancer Survival rates for the disease that killed Tessa Jowell are poor. Now a Labour MP whose sister was diagnosed with glioblastoma is calling for action after a specialist said sufferers were being neglected by the medical establishment Tessa Jowell, with her Dame Commander insignia in 2013, died of the disease in 2018
“I’m not a woman given to crying in public. I’m a bit old. I’m not part of that generation which emotes and talks about personal stuff,” says Siobhain McDonagh, the Labour MP. “It doesn’t feel that comfortable.”
In a moving speech in the Commons last month, her voice broke as she described being there when her sister, Margaret McDonagh, collapsed at a party in November 2021, and was rushed to hospital in an ambulance. The peer was diagnosed with glioblastoma, the most common form of brain tumour. It is the disease that killed the Labour former cabinet minister Tessa Jowell in 2018.
The MP decided public discomfort was a “price worth paying” in a campaign to improve the chances of brain tumour patients like her sister via opportunities to take part in research and better training for NHS doctors.
Siobhain McDonagh gave a moving speech in the Commons about the disease last month
What is currently the “gold standard” treatment for glioblastoma on the NHS “shouldn’t even be called a plastic standard”, she says.
The 3,200 people diagnosed with glioblastoma in the UK each year follow a well-worn trail. First, surgery to remove as much of the tumour as possible. Then, if they are well enough, radiotherapy. Then chemotherapy, with a drug called temozolomide, first trialled in the 1970s. Many die before completing treatment.
McDonagh was too unwell to withstand the chemotherapy. The family have sought private care from Dr Paul Mulholland, a specialist in glioblastoma at University College Hospital (UCH), London.
He has put her on a regime of immunotherapies and hyperthermic treatment, which involves raising the temperature around the tumour in an attempt to boost the drug’s efficacy.
Margaret McDonagh first had to travel to Germany for the treatment she requires Margaret McDonagh first had to travel to Germany for the treatment she requires RICHARD GARDNEREX/SHUTTERSTOCK Siobhain McDonagh had to take her sister to Germany for the hyperthermic treatment, before Mulholland got a machine to deliver it in London, sometimes fearing they would not be allowed on board the plane because Margaret was so unwell.
As glioblastoma patients go, they are “on the lucky end”, she insists, with a good support network, the option of private treatment and a reasonably swift diagnosis.
Even so, it is “a struggle”. She has to pause a number of times while speaking to The Times to take calls resolving a problem with the company that is supposed to be delivering drugs for her sister.
“I want everybody to have the options I’ve had, but I don’t want them to be as difficult,” McDonagh says.
Siobhain McDonagh with Dr Paul Mulholland, the brain cancer specialist treating her sister, who says patients are being neglected and there must be more clinical trials for patients and more doctors trained Siobhain McDonagh with Dr Paul Mulholland, the brain cancer specialist treating her sister, who says patients are being neglected and there must be more clinical trials for patients and more doctors trained TIMES PHOTOGRAPHER JACK HILL She asked ministers to get 200 sufferers a year access to a trial and commit to medical oncologists being trained on brain tumours.
Patients newly diagnosed with glioblastoma “go on their smartphone and they google it”, says Mulholland. The words that stare back at them are “death, dying, terminal”.
“The average survival for glioblastoma is nine months,” he says. It is perhaps surprising, then, to hear Mulholland insist: “I’m actually very optimistic that we will cure it, and it could be very soon.”
A push on getting patients into clinical trials, and more training for young doctors in the disease, the most common form of brain tumour, could pay rapid dividends, he says.
There have been few advances in care in decades because patients are being “neglected” by the medical establishment and pharmaceutical industry, Mulholland says bluntly.
The number of patients with glioblastoma, which he sees as an “absolute epidemic, shocking epidemic”, is nonetheless “not enough for a business case” to encourage companies to test their new drugs against the cancer.
Doctors training to become medical oncologists, specialists in using drugs to treat cancers and in clinical trials, are not required to spend any time at all training in brain cancer.
Although, Mulholland notes: “They do a year of bowel cancer and so they have to do six months of lower bowel cancer and six months of upper bowel cancer. So people can ponder that.”
The NHS does not require medical oncologists to be present at the multidisciplinary team meetings discussing patients with glioblastoma, so the people most likely to know about the few clinical trials of new treatments are not in the room when decisions are being made about patients’ options.
ADVERTISEMENT
That all needs to change, Mulholland says. “I think that we need to make a commitment, as a country, that we put 200 glioblastoma patients into a trial [each year] that might change the outcome of their disease.
“I don’t mean a trial where you give them a little bit of cannabis to see if it makes them [feel] better. I mean, a real drug that might cure the disease.”
There are good reasons to think that immunotherapies called checkpoint inhibitors, which target the complex neighbourhood of cells in and around a tumour, should help in glioblastoma. Mulholland is confident using them in his private practice for patients like Margaret.
But the drugs are expensive, he says. “People do have more choices if they’ve got health insurance. And that’s not a position that makes me comfortable. And that’s why I want to do these trials, so that we’re not in this position. So I want to get real data in real trials, and offer people good treatment. And it would be then, when we’ve got good data, we can treat people in the NHS.”
The target of 200 patients is very achievable, Mulholland says, suggesting they be put in groups of 12 initially, to try different treatment combinations, going on to broader trials in those that seem to work.
Patients and families are “shocked” at their lack of options, he says. “People start searching for these trials that aren’t there. They’re up, they are awake at three o’clock in the morning looking for their relatives’ trials, and then they come and show me and I say, ‘But that’s not brain cancer. That’s for breast cancer. That’s for this, that for that . . .’
“I know what’s there. They really are looking for the needle in the haystack. There are very, very few trial opportunities for patients.”
ADVERTISEMENT
Mulholland recently ran a trial of immunotherapy in 119 glioblastoma patients at UCH, the results of which will be announced at an American Society for Clinical Oncology conference in Chicago this year. But The National Brain Appeal charity had to step in to provide funding because he could not get it elsewhere.
He is now recruiting for a new trial. It aims to try immunotherapy before surgery, and so requires patients to come forward very soon after diagnosis. Interested people should ask their doctors and nurses to contact his team at UCH.
“If you want a different survival [rate], you’re going to have to do something different,” Mullholland says. “You can’t just keep repeating the same thing.”
COMMENTS:
Comments are subject to our community standards and participation guidelines policy, which can be viewed here. By joining the conversation you are accepting our community rules and terms. Update your commenting notification settings here. Our policy is for readers to use their real names when commenting, find out more here. joe pratt
Sort by
Recommended A Smith 10 APRIL, 2023
This article is shocking. Where are the comments from NHS England and NICE? Both of them have questions to answer.
Reply
Recommend (60)
Share A Collins 10 APRIL, 2023
Please can the subeditor for this article have a good think about whether the headline is appropriate. To me, it seems to sensationalise the piece. The story in the body of the text is that Glioblastoma Multiforme (GBM) is still a rotten diagnosis with an average prognosis of 9 months of poor healt...
See more
Reply
Recommend (36)
Share Chris Bolton 10 APRIL, 2023
This headline is typical of The Times. Headlines are designed to encourage people to read the article, and the headline writer doesn't seem to care whether they're accurate. There's no point getting people to read the article if they then stop subscribing to the paper.
Reply
Recommend (5)
Share S harris 10 APRIL, 2023
The lack of research into this cancer is shocking.
Reply
Recommend (35)
Share Richard Smith 10 APRIL, 2023
A good friend of mine died of this in his early 50's. He had surgery which seemed to slow it down for a while, and then immunotherapy, but it came back a few months later.
The stats are absolutely awful. I remember telling a work colleague at the time I found out about his diagnosis and his reply w...
See more
Reply
Recommend (25)
Share Jimmy P 10 APRIL, 2023
The headline is a little misleading, there is little to suggest that trials can cure glioblastoma, at least in the short or medium term. Also misleading to suggest that immune checkpoint inhibitors are the answer - while v effective in melanoma, renal cell carcinoma, some lung cancer - they are of ...
See more
Reply
Recommend (24)
Share Sahra Durnford 10 APRIL, 2023
Agree. Reads more like an advertorial for expensive treatments with limited and unproven efficacy.
Reply
Recommend (7)
Share Emily Chatwin 10 APRIL, 2023
This is the disease that killed my Aunt when she was in her 40',s and my father in his early 70's, so I devoured this article the headline with its "could be cured with trials" is an absolute journalistic disgrace.
Reply
Recommend (17)
Share L I Shigaev 10 APRIL, 2023
I am sorry for your loss, thank you for sharing.
As for this piece, in particular the headline, I feel as though I have gone through a similar emotional journey to you as I went from headline through the article. I’m feeling quite low now, with my hope having been dashed
Reply
Recommend (4)
Share Mick Mahon 10 APRIL, 2023
Read this click bait article thinking it was going to describe new treatments to cure this evil thing that brutalised & took the love of my life before her 50th birthday. Why would ToL publish such a shabby hopeful headline then go on to confirm there is no new glioblastoma multiform treatment and ...
See more
Reply
Recommend (12)
Share N Lancaster 10 APRIL, 2023
My sister died of it in 2019. She was always hopeful of finding an alternative "treatment" to what she got. It only prolonged her discomfort.
Reply
Recommended (0)
Share Alan Mowle 10 APRIL, 2023
The problem is really, really skilled Doctors. The treatment Dr.Mullholand used with the hyperthermic approach, is delicate and time consuming and needs the right machine to increase the temperature around the cancer tissue, and get an enhanced anti-cancer response from the immunotherapy drugs. Tim...
See more
Reply
Recommend (12)
Share Anne Chitnis 10 APRIL, 2023
My son died in the seventies from “a deep and silent” brain tumour, aged seven years old. It doesn’t seem to me that treatment has advanced at all since then. As for other cancers, such as breast cancer or prostate cancer, the research goes where the money is. We all have a father, perhaps vuln...
See more
Reply
Recommend (9)
Share Rob Parkes 10 APRIL, 2023
Where should one put research funds?
Into rare tumours that affect very few people or common problems that affect and would benefit large numbers.
Reply
Recommend (2)
Share
1 reply James Robinson 10 APRIL, 2023
There are well over a 100 different forms of brain tumour - some benign and curable, some benign but dangerous and some cancerous that could spread. They disproportionately affect younger people and children, but research expenditure is shocking and the treatment often brutal.
I really hope the opt...
See more
Reply
Recommend (6)
Share H D Lewis 10 APRIL, 2023
Another area of shame for the UK. But will resources be put into this?
Reply
Recommend (5)
Share Rob Parkes 10 APRIL, 2023
Research is done world wide so it is not 'just down to the UK' to solve it.
Reply
Recommend (2)
Share Nicolas Crowhurstt 10 APRIL, 2023
Why is it that the ad in the article saying first symptoms of a brain tumour has absolutely nothing about a brain tumour?
Does the Times even check what it's ads say?
Reply
Recommend (4)
Share Norman Goldner 10 APRIL, 2023
we are getting closer and closer to better treatments and then cures for cancer. Development of the mRNA vaccine for COVID opened up new research routes that will lead to new treatments, which hopefully will be here by the end of the decade.
Thank you to the scientists who are making this possible. ...
See more
Reply
Recommend (3)
Share Michael Lingard 10 APRIL, 2023
We must remember that most research is funded by the pharmaceutical companies and that they rank as the most profitable companies on the stock exchange. There has to be a better way of funding medical research than what is likely to be the most profitable new drug when other therapeutic approaches ...
See more
Reply
Recommend (2)
Share Ann Jackson 10 APRIL, 2023
Please G-d
Reply
Recommend (1)
Share Patrick Moffat 11 APRIL, 2023
I don’t mean a trial where you give them a little bit of cannabis to see if it makes them [feel] better. I mean, a real drug that might cure the disease.
This appears to be a snide and somewhat disingenuous reference to a trial overseen by Professor Susan Short, chief oncologist at Leeds university....
See more
Reply
Recommend (1)
Share N Morris 10 APRIL, 2023
Nothing much for ocular melanoma either. Prognosis after mets to liver? Six months
Reply
Recommend (1)
Share Virginia Crook 10 APRIL, 2023
Please, Times, why do I have to keep “signing up to post” when I’ve been doing it since 2019!
Reply
Recommend (1)
Share Katherine Barnes 11 APRIL, 2023
I agree it’s quite distressing to read that there could be a cure I’ve just lost my husband to glioblastoma. But yes to more research and clinical trials please so people have longer and more hope.
Reply
Recommend (1)
Share Ryan Meade 11 APRIL, 2023
My best friend passed away from a Glioblastoma tumour in 2014 at the age of 27. He got 4 years after his diagnosis mostly thanks to Dr Charlie Teo agreeing to do his surgery for free so soon after his diagnosis. Thoughts go out to anyone to have had friends or family succumb to this awful disease a...
See more
Reply
Recommended (0)
Share Hugh Duncan 10 APRIL, 2023
I was a Labour party member in SW19 in the 1980s and used to know both Margaret and Siobhan - Both great and friendly people.
Greatly sad to hear of Margaret's condition.
I'm surprised though that Siobhan has managed to keep her plain normality (and her attractiveness if one is allowed to say that...
Mick Mahon 10 APRIL, 2023 Read this click bait article thinking it was going to describe new treatments to cure this evil thing that brutalised & took the love of my life before her 50th birthday. Why would ToL publish such a shabby hopeful headline then go on to confirm there is no new glioblastoma multiform treatment and no new hope in the near or long term future! The sad fact is that nothing has changed - that should have been the headline! The treatment remains the same as it’s always been - cut, nuke, poison the tumour and repeat until the patient can endure no more. The treatment compounding the debilitating pain & grim misery of being turned into a vegetable by the brutal medical assault on the brain and body during the short few weeks / months of a living hell!
COMMENTS:
Jimmy P 10 APRIL, 2023 The headline is a little misleading, there is little to suggest that trials can cure glioblastoma, at least in the short or medium term. Also misleading to suggest that immune checkpoint inhibitors are the answer - while v effective in melanoma, renal cell carcinoma, some lung cancer - they are of modest benefit in other cancers. As for therapeutic hyperthermia etc available in Germany, little robust data to support their use. While there is research in GBM, clearly it is dwarfed by that in breast cancer, prostate cancer. Not sure how that can be redressed.
That all needs to change, Mulholland says. “I think that we need to make a commitment, as a country, that we put 200 glioblastoma patients into a trial [each year] that might change the outcome of their disease.
“The average survival for glioblastoma is nine months,” he says. It is perhaps surprising, then, to hear Mulholland insist: “I’m actually very optimistic that we will cure it, and it could be very soon.”
"Expert urges drug trial that could lead to cure for most common brain cancer."
"The target of 200 patients is very achievable, Mulholland says, suggesting they be put in groups of 12 initially, to try different treatment combinations, going on to broader trials in those that seem to work."📷 2 Likes Share Reply/Post Keep Last Read More Next 10 Prev NextNWBONorthwest Biotherapeutics Inc (QB)0.53 -0.0217 (-3.93%)Volume:1,752,095Day Range:0.53 - 0.569Bid:0.53Ask:0.535Last Trade Time:2:54:56 PM EDTTotal Trades:509
📷
NWBO Detailed Quote
submitted by jhpratt2 to NWBO [link] [comments]


2023.04.15 11:33 carlyszabo Do you think she is disappointed? (.)(.)

I’m not against having plastic surgery at all. Each to their own. I personally wouldn’t get implants because of breast implant illness but after multiple pregnancies I get why someone would want them.
Emilie seemed pretty flat chested before and these implants to me have made minimal difference. If you going to spend the money and have the surgery why not go a bit bigger? I know it’s a risk choosing the size but 235cc really is on the way smaller end especially considering she had nothing to work with .
I personally would be so disappointed with the result that I can’t help but wonder if she is?
submitted by carlyszabo to emiliekisersnark1 [link] [comments]


http://activeproperty.pl/